February 28, 2020 | |
(as revised June 30, 2020) |
2020 Prospectus |
• | iShares iBonds 2021 Term High Yield and Income ETF* | IBHA | CBOE BZX |
|
S-1 |
|
1 |
|
2 |
|
16 |
|
20 |
|
20 |
|
23 |
|
32 |
|
33 |
|
34 |
|
34 |
|
37 |
Ticker: IBHA | Stock Exchange: Cboe BZX |
Annual Fund Operating Expenses (ongoing expenses that you pay each year as a percentage of the value of your investments) |
||||||||||||
Management Fees |
Distribution and Service (12b-1) Fees |
Other Expenses1 |
Acquired Fund Fees and Expenses1,2 |
Total Annual Fund Operating Expenses |
Fee Waiver1,2 | Total Annual Fund Operating Expenses After Fee Waiver |
||||||
0.35% | None | 0.00% | 0.00% | 0.35% | (0.00)% | 0.35% |
1 | The amount rounded to 0.00%. |
2 | BFA, the investment adviser to the Fund, has contractually agreed to waive a portion of its management fees in an amount equal to the Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its affiliates through the termination date of the Fund, on or about December 15, 2021. The contractual waiver may be terminated prior to the Fund's termination only upon the written agreement of the Trust and BFA. |
1 Year | Maturity | |||
$36 | $66 |
■ | High yield securities may be issued by less creditworthy issuers. Issuers of high yield securities may have a larger amount of outstanding debt relative to their assets than issuers of investment-grade bonds. In the event of an issuer’s bankruptcy, claims of other creditors may have priority over the claims of high yield securities holders, leaving few or no assets available to repay high yield securities holders. |
■ | Prices of high yield securities are subject to extreme price fluctuations. Adverse changes in an issuer’s industry and general economic conditions may have a greater impact on the prices of high yield securities than on other higher rated fixed-income securities. The credit rating of a high yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer. |
■ | Issuers of high yield securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing. |
■ | High yield securities frequently have redemption features that permit an issuer to repurchase the security from the Fund before it matures. If the issuer redeems high yield securities held by the Fund, the Fund may have to invest the proceeds in bonds with lower yields and may lose income. Such use of proceeds will occur when the Fund invests in BBB-rated bonds from the Corporate Index. |
■ | High yield securities may be less liquid than higher rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the high yield securities market, and there may be significant differences in the prices quoted for high yield securities by the dealers. Because high yield securities may be less liquid than higher rated fixed-income securities, judgment may play a greater role in |
valuing certain of the Fund's securities than is the case with securities trading in a more liquid market. | |
■ | The Fund may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer. |
■ | General Impact. This outbreak has resulted in travel restrictions, closed international borders, enhanced health screenings at ports of entry and elsewhere, disruption of and delays in healthcare service preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions, lower consumer demand, temporary closures of stores, restaurants and other commercial establishments, layoffs, defaults and other significant economic impacts, as well as general concern and uncertainty. |
■ | Market Volatility. The outbreak has also resulted in extreme volatility, severe losses, and disruptions in markets which can adversely impact the Fund and its investments, including impairing hedging activity to the extent a Fund engages in such activity, as expected correlations between related markets or instruments may no longer apply. In addition, to the extent the Fund invests in short-term instruments that have negative yields, the Fund’s value may be impaired as a result. Certain issuers of equity securities have cancelled or announced the suspension of dividends. The outbreak has, and may continue to, negatively affect the credit ratings of some fixed income securities and their issuers. |
■ | Market Closures. Certain local markets have been or may be subject to closures, and there can be no assurance that trading will continue in any local markets in which the Fund may invest, when any resumption of trading will occur or, once such markets resume trading, whether they will face further closures. Any suspension of trading in markets in which the Fund invests will have an impact on the Fund and its investments and will impact the Fund’s ability to purchase or sell securities in such markets. |
■ | Operational Risk. The outbreak could also impair the information technology and other operational systems upon which the Fund’s service providers, including BFA, rely, and could otherwise disrupt the ability of employees of the Fund’s service providers to perform critical tasks relating to the Fund, for example, due to the service providers’ employees performing tasks in alternate locations than under normal operating conditions or the illness of certain employees of the Fund’s service providers. |
■ | Governmental Interventions. Governmental and quasi-governmental authorities and regulators throughout the world have responded to the outbreak and the resulting economic disruptions with a variety of fiscal and monetary policy changes, including direct capital infusions into companies and other issuers, new monetary policy tools, and lower interest rates. An unexpected or sudden reversal of these policies, or the ineffectiveness of such policies, is likely to increase market volatility, which could adversely affect the Fund’s investments. |
■ | Pre-Existing Conditions. Public health crises caused by the outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. |
Approximate Value of a Creation Unit |
Creation Unit Size |
Standard Creation/ Redemption Transaction Fee |
Maximum Additional Charge for Creations* |
Maximum Additional Charge for Redemptions* |
||||
$2,489,000 | 100,000 | $650 | 3.0% | 2.0% |
* | As a percentage of the net asset value per Creation Unit, inclusive, in the case of redemptions, of the standard redemption transaction fee. |
iShares iBonds 2021 Term High Yield and Income ETF | |
Period From 05/07/19(a) to 10/31/19 |
|
Net asset value, beginning of period | $25.00 |
Net investment income(b) | 0.58 |
Net realized and unrealized loss(c) | (0.20) |
Net increase from investment operations | 0.38 |
Distributions(d) | |
From net investment income | (0.47) |
Total distributions | (0.47) |
Net asset value, end of period | $24.91 |
Total Return | |
Based on net asset value | 1.54%(e) |
Ratios to Average Net Assets | |
Total expenses | 0.35%(f) |
Net investment income | 4.76%(f) |
Supplemental Data | |
Net assets, end of period (000) | $12,454 |
Portfolio turnover rate(g) | 17%(e) |
(a) Commencement of operations. |
|
(b) Based on average shares outstanding. | |
(c) The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities. | |
(d) Distributions for annual periods determined in accordance with U.S. federal income tax regulations. | |
(e) Not annualized. | |
(f) Annualized. | |
(g) Portfolio turnover rate excludes in-kind transactions. |
Premium/Discount Range | Number of Days | Percentage of Total Days | ||
Greater than 0.5% and Less than 1.0% | 3 | 1.83% | ||
Greater than 0.0% and Less than 0.5% | 152 | 92.68 | ||
Less than 0.0% and Greater than -0.5% | 9 | 5.49 | ||
164 | 100.00% |
Cumulative Total Returns | ||
Since Inception |
||
Fund NAV | 1.54% | |
Fund Market | 1.66 | |
Index | 1.50 |
Total returns for the period since inception are calculated from the inception date of the Fund (5/7/19). The first day of secondary market trading in shares of the Fund was 5/9/19. |
Call: | 1-800-iShares or 1-800-474-2737 (toll free) Monday through Friday, 8:30 a.m. to 6:30 p.m. (Eastern time) |
Email: | iSharesETFs@blackrock.com |
Write: | c/o BlackRock Investments, LLC 1 University Square Drive, Princeton, NJ 08540 |
February 28, 2020 | |
(as revised June 30, 2020) |
2020 Prospectus |
• | iShares iBonds 2022 Term High Yield and Income ETF* | IBHB | CBOE BZX |
|
S-1 |
|
1 |
|
2 |
|
16 |
|
21 |
|
21 |
|
24 |
|
32 |
|
34 |
|
35 |
|
35 |
|
38 |
Ticker: IBHB | Stock Exchange: Cboe BZX |
Annual Fund Operating Expenses (ongoing expenses that you pay each year as a percentage of the value of your investments) |
||||||||||||
Management Fees |
Distribution and Service (12b-1) Fees |
Other Expenses1 |
Acquired Fund Fees and Expenses1,2 |
Total Annual Fund Operating Expenses |
Fee Waiver1,2 | Total Annual Fund Operating Expenses After Fee Waiver |
||||||
0.35% | None | 0.00% | 0.00% | 0.35% | (0.00)% | 0.35% |
1 | The amount rounded to 0.00%. |
2 | BFA, the investment adviser to the Fund, has contractually agreed to waive a portion of its management fees in an amount equal to the Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its affiliates through the termination date of the Fund, on or about December 15, 2022. The contractual waiver may be terminated prior to the Fund's termination only upon the written agreement of the Trust and BFA. |
1 Year | Maturity | |||
$36 | $105 |
■ | High yield securities may be issued by less creditworthy issuers. Issuers of high yield securities may have a larger amount of outstanding debt relative to their assets than issuers of investment-grade bonds. In the event of an issuer’s bankruptcy, claims of other creditors may have priority over the claims of high yield securities holders, leaving few or no assets available to repay high yield securities holders. |
■ | Prices of high yield securities are subject to extreme price fluctuations. Adverse changes in an issuer’s industry and general economic conditions may have a greater impact on the prices of high yield securities than on other higher rated fixed-income securities. The credit rating of a high yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer. |
■ | Issuers of high yield securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing. |
■ | High yield securities frequently have redemption features that permit an issuer to repurchase the security from the Fund before it matures. If the issuer redeems high yield securities held by the Fund, the Fund may have to invest the proceeds in bonds with lower yields and may lose income. Such use of proceeds will occur when the Fund invests in BBB-rated bonds from the Corporate Index. |
■ | High yield securities may be less liquid than higher rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the high yield securities market, and there may be significant differences in the prices quoted for high yield securities by the dealers. Because high yield securities may be less liquid than higher rated fixed-income securities, judgment may play a greater role in valuing certain of the Fund's securities than is the case with securities trading in a more liquid market. |
■ | The Fund may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer. |
■ | General Impact. This outbreak has resulted in travel restrictions, closed international borders, enhanced health screenings at ports of entry and elsewhere, disruption of and delays in healthcare service preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions, lower consumer demand, temporary closures of stores, restaurants and other commercial establishments, layoffs, defaults and other significant economic impacts, as well as general concern and uncertainty. |
■ | Market Volatility. The outbreak has also resulted in extreme volatility, severe losses, |
■ | Market Closures. Certain local markets have been or may be subject to closures, and there can be no assurance that trading will continue in any local markets in which the Fund may invest, when any resumption of trading will occur or, once such markets resume trading, whether they will face further closures. Any suspension of trading in markets in which the Fund invests will have an impact on the Fund and its investments and will impact the Fund’s ability to purchase or sell securities in such markets. |
■ | Operational Risk. The outbreak could also impair the information technology and other operational systems upon which the Fund’s service providers, including BFA, rely, and could otherwise disrupt the ability of employees of the Fund’s service providers to perform critical tasks relating to the Fund, for example, due to the service providers’ employees performing tasks in alternate locations than under normal operating conditions or the illness of certain employees of the Fund’s service providers. |
■ | Governmental Interventions. Governmental and quasi-governmental authorities and regulators throughout the world have responded to the outbreak and the resulting economic disruptions with a variety of fiscal and monetary policy changes, including direct capital infusions into companies and other issuers, new monetary policy tools, and lower interest rates. An unexpected or sudden reversal of these policies, or the ineffectiveness of such policies, is likely to increase market volatility, which could adversely affect the Fund’s investments. |
■ | Pre-Existing Conditions. Public health crises caused by the outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. |
Approximate Value of a Creation Unit |
Creation Unit Size |
Standard Creation/ Redemption Transaction Fee |
Maximum Additional Charge for Creations* |
Maximum Additional Charge for Redemptions* |
||||
$2,457,000 | 100,000 | $825 | 3.0% | 2.0% |
* | As a percentage of the net asset value per Creation Unit, inclusive, in the case of redemptions, of the standard redemption transaction fee. |
iShares iBonds 2022 Term High Yield and Income ETF | |
Period From 05/07/19(a) to 10/31/19 |
|
Net asset value, beginning of period | $25.00 |
Net investment income(b) | 0.64 |
Net realized and unrealized loss(c) | (0.51) |
Net increase from investment operations | 0.13 |
Distributions(d) | |
From net investment income | (0.54) |
Total distributions | (0.54) |
Net asset value, end of period | $24.59 |
Total Return | |
Based on net asset value | 0.56%(e) |
Ratios to Average Net Assets | |
Total expenses | 0.35%(f) |
Net investment income | 5.34%(f) |
Supplemental Data | |
Net assets, end of period (000) | $9,838 |
Portfolio turnover rate(g) | 14%(e) |
(a) Commencement of operations. |
|
(b) Based on average shares outstanding. | |
(c) The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities. | |
(d) Distributions for annual periods determined in accordance with U.S. federal income tax regulations. | |
(e) Not annualized. | |
(f) Annualized. | |
(g) Portfolio turnover rate excludes in-kind transactions. |
Premium/Discount Range | Number of Days | Percentage of Total Days | ||
Greater than 0.5% and Less than 1.0% | 4 | 2.44% | ||
Greater than 0.0% and Less than 0.5% | 149 | 90.85 | ||
At NAV | 2 | 1.22 | ||
Less than 0.0% and Greater than -0.5% | 9 | 5.49 | ||
164 | 100.00% |
Cumulative Total Returns | ||
Since Inception |
||
Fund NAV | 0.56% | |
Fund Market | 0.72 | |
Index | 1.10 |
Total returns for the period since inception are calculated from the inception date of the Fund (5/7/19). The first day of secondary market trading in shares of the Fund was 5/9/19. |
Call: | 1-800-iShares or 1-800-474-2737 (toll free) Monday through Friday, 8:30 a.m. to 6:30 p.m. (Eastern time) |
Email: | iSharesETFs@blackrock.com |
Write: | c/o BlackRock Investments, LLC 1 University Square Drive, Princeton, NJ 08540 |
February 28, 2020 | |
(as revised June 30, 2020) |
2020 Prospectus |
• | iShares iBonds 2023 Term High Yield and Income ETF* | IBHC | CBOE BZX |
|
S-1 |
|
1 |
|
2 |
|
16 |
|
21 |
|
21 |
|
24 |
|
33 |
|
34 |
|
35 |
|
35 |
|
38 |
Ticker: IBHC | Stock Exchange: Cboe BZX |
Annual Fund Operating Expenses (ongoing expenses that you pay each year as a percentage of the value of your investments) |
||||||||||||
Management Fees |
Distribution and Service (12b-1) Fees |
Other Expenses1 |
Acquired Fund Fees and Expenses1,2 |
Total Annual Fund Operating Expenses |
Fee Waiver1,2 | Total Annual Fund Operating Expenses After Fee Waiver |
||||||
0.35% | None | 0.00% | 0.00% | 0.35% | (0.00)% | 0.35% |
1 | The amount rounded to 0.00%. |
2 | BFA, the investment adviser to the Fund, has contractually agreed to waive a portion of its management fees in an amount equal to the Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its affiliates through the termination date of the Fund, on or about December 15, 2023. The contractual waiver may be terminated prior to the Fund's termination only upon the written agreement of the Trust and BFA. |
1 Year | 3 Years | |||
$36 | $113 |
■ | High yield securities may be issued by less creditworthy issuers. Issuers of high yield securities may have a larger amount of outstanding debt relative to their assets than issuers of investment-grade bonds. In the event of an issuer’s bankruptcy, claims of other creditors may have priority over the claims of high yield securities holders, leaving few or no assets available to repay high yield securities holders. |
■ | Prices of high yield securities are subject to extreme price fluctuations. Adverse changes in an issuer’s industry and general economic conditions may have a greater impact on the prices of high yield securities than on other higher rated fixed-income securities. The credit rating of a high yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer. |
■ | Issuers of high yield securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing. |
■ | High yield securities frequently have redemption features that permit an issuer to repurchase the security from the Fund before it matures. If the issuer redeems high yield securities held by the Fund, the Fund may have to invest the proceeds in bonds with lower yields and may lose income. Such use of proceeds will occur when the Fund invests in BBB-rated bonds from the Corporate Index. |
■ | High yield securities may be less liquid than higher rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the high yield securities market, and there may be significant differences in the prices quoted for high yield securities by the dealers. Because high yield securities may be less liquid than higher rated fixed-income securities, judgment may play a greater role in |
valuing certain of the Fund's securities than is the case with securities trading in a more liquid market. | |
■ | The Fund may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer. |
■ | General Impact. This outbreak has resulted in travel restrictions, closed international borders, enhanced health screenings at ports of entry and elsewhere, disruption of and delays in healthcare service preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions, lower consumer demand, temporary closures of stores, restaurants and other commercial establishments, layoffs, defaults and other significant economic impacts, as well as general concern and uncertainty. |
■ | Market Volatility. The outbreak has also resulted in extreme volatility, severe losses, and disruptions in markets which can adversely impact the Fund and its investments, including impairing hedging activity to the extent a Fund engages in such activity, as expected correlations between related markets or instruments may no longer apply. In addition, to the extent the Fund invests in short-term instruments that have negative yields, the Fund’s value may be impaired as a result. Certain issuers of equity securities have cancelled or announced the suspension of dividends. The outbreak has, and may continue to, negatively affect the credit ratings of some fixed income securities and their issuers. |
■ | Market Closures. Certain local markets have been or may be subject to closures, and there can be no assurance that trading will continue in any local markets in which the Fund may invest, when any resumption of trading will occur or, once such markets resume trading, whether they will face further closures. Any suspension of trading in markets in which the Fund invests will have an impact on the Fund and its investments and will impact the Fund’s ability to purchase or sell securities in such markets. |
■ | Operational Risk. The outbreak could also impair the information technology and other operational systems upon which the Fund’s service providers, including BFA, rely, and could otherwise disrupt the ability of employees of the Fund’s service providers to perform critical tasks relating to the Fund, for example, due to the service providers’ employees performing tasks in alternate locations than under normal operating conditions or the illness of certain employees of the Fund’s service providers. |
■ | Governmental Interventions. Governmental and quasi-governmental authorities and regulators throughout the world have responded to the outbreak and the resulting economic disruptions with a variety of fiscal and monetary policy changes, including direct capital infusions into companies and other issuers, new monetary policy tools, and lower interest rates. An unexpected or sudden reversal of these policies, or the ineffectiveness of such policies, is likely to increase market volatility, which could adversely affect the Fund’s investments. |
■ | Pre-Existing Conditions. Public health crises caused by the outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. |
Approximate Value of a Creation Unit |
Creation Unit Size |
Standard Creation/ Redemption Transaction Fee |
Maximum Additional Charge for Creations* |
Maximum Additional Charge for Redemptions* |
||||
$2,468,000 | 100,000 | $925 | 3.0% | 2.0% |
* | As a percentage of the net asset value per Creation Unit, inclusive, in the case of redemptions, of the standard redemption transaction fee. |
iShares iBonds 2023 Term High Yield and Income ETF | |
Period From 05/07/19(a) to 10/31/19 |
|
Net asset value, beginning of period | $25.00 |
Net investment income(b) | 0.69 |
Net realized and unrealized loss(c) | (0.40) |
Net increase from investment operations | 0.29 |
Distributions(d) | |
From net investment income | (0.56) |
Total distributions | (0.56) |
Net asset value, end of period | $24.73 |
Total Return | |
Based on net asset value | 1.19%(e) |
Ratios to Average Net Assets | |
Total expenses | 0.35%(f) |
Net investment income | 5.73%(f) |
Supplemental Data | |
Net assets, end of period (000) | $12,364 |
Portfolio turnover rate(g) | 9%(e) |
(a) Commencement of operations. |
|
(b) Based on average shares outstanding. | |
(c) The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities. | |
(d) Distributions for annual periods determined in accordance with U.S. federal income tax regulations. | |
(e) Not annualized. | |
(f) Annualized. | |
(g) Portfolio turnover rate excludes in-kind transactions. |
Premium/Discount Range | Number of Days | Percentage of Total Days | ||
Greater than 0.5% and Less than 1.0% | 7 | 4.27% | ||
Greater than 0.0% and Less than 0.5% | 143 | 87.19 | ||
At NAV | 3 | 1.83 | ||
Less than 0.0% and Greater than -0.5% | 11 | 6.71 | ||
164 | 100.00% |
Cumulative Total Returns | ||
Since Inception |
||
Fund NAV | 1.19% | |
Fund Market | 1.31 | |
Index | 1.87 |
Total returns for the period since inception are calculated from the inception date of the Fund (5/7/19). The first day of secondary market trading in shares of the Fund was 5/9/19. |
Call: | 1-800-iShares or 1-800-474-2737 (toll free) Monday through Friday, 8:30 a.m. to 6:30 p.m. (Eastern time) |
Email: | iSharesETFs@blackrock.com |
Write: | c/o BlackRock Investments, LLC 1 University Square Drive, Princeton, NJ 08540 |
February 28, 2020 | |
(as revised June 30, 2020) |
2020 Prospectus |
• | iShares iBonds 2024 Term High Yield and Income ETF* | IBHD | CBOE BZX |
|
S-1 |
|
1 |
|
2 |
|
16 |
|
22 |
|
22 |
|
25 |
|
34 |
|
35 |
|
36 |
|
36 |
|
39 |
Ticker: IBHD | Stock Exchange: Cboe BZX |
Annual Fund Operating Expenses (ongoing expenses that you pay each year as a percentage of the value of your investments) |
||||||||||||
Management Fees |
Distribution and Service (12b-1) Fees |
Other Expenses1 |
Acquired Fund Fees and Expenses1,2 |
Total Annual Fund Operating Expenses |
Fee Waiver1,2 | Total Annual Fund Operating Expenses After Fee Waiver |
||||||
0.35% | None | 0.00% | 0.00% | 0.35% | (0.00)% | 0.35% |
1 | The amount rounded to 0.00%. |
2 | BFA, the investment adviser to the Fund, has contractually agreed to waive a portion of its management fees in an amount equal to the Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its affiliates through the termination date of the Fund, on or about December 15, 2024. The contractual waiver may be terminated prior to the Fund's termination only upon the written agreement of the Trust and BFA. |
1 Year | 3 Years | |||
$36 | $113 |
■ | High yield securities may be issued by less creditworthy issuers. Issuers of high yield securities may have a larger amount of outstanding debt relative to their assets than issuers of investment-grade bonds. In the event of an issuer’s bankruptcy, claims of other creditors may have priority over the claims of high yield securities holders, leaving few or no assets available to repay high yield securities holders. |
■ | Prices of high yield securities are subject to extreme price fluctuations. Adverse changes in an issuer’s industry and general economic conditions may have a greater impact on the prices of high yield securities than on other higher rated fixed-income securities. The credit rating of a high yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer. |
■ | Issuers of high yield securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing. |
■ | High yield securities frequently have redemption features that permit an issuer to repurchase the security from the Fund before it matures. If the issuer redeems high yield securities held by the Fund, the Fund may have to invest the proceeds in bonds with lower yields and may lose income. Such use of proceeds will occur when the Fund invests in BBB-rated bonds from the Corporate Index. |
■ | High yield securities may be less liquid than higher rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the high yield securities market, and there may be significant differences in the prices quoted for high yield securities by the dealers. Because high yield securities may be less liquid than higher rated fixed-income securities, judgment may play a greater role in valuing certain of the Fund's securities than is the case with securities trading in a more liquid market. |
■ | The Fund may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer. |
■ | General Impact. This outbreak has resulted in travel restrictions, closed international borders, enhanced health screenings at ports of entry and elsewhere, disruption of and delays in healthcare service preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions, lower consumer demand, temporary closures of stores, restaurants and other commercial establishments, layoffs, defaults and other significant economic impacts, as well as general concern and uncertainty. |
■ | Market Volatility. The outbreak has also resulted in extreme volatility, severe losses, |
■ | Market Closures. Certain local markets have been or may be subject to closures, and there can be no assurance that trading will continue in any local markets in which the Fund may invest, when any resumption of trading will occur or, once such markets resume trading, whether they will face further closures. Any suspension of trading in markets in which the Fund invests will have an impact on the Fund and its investments and will impact the Fund’s ability to purchase or sell securities in such markets. |
■ | Operational Risk. The outbreak could also impair the information technology and other operational systems upon which the Fund’s service providers, including BFA, rely, and could otherwise disrupt the ability of employees of the Fund’s service providers to perform critical tasks relating to the Fund, for example, due to the service providers’ employees performing tasks in alternate locations than under normal operating conditions or the illness of certain employees of the Fund’s service providers. |
■ | Governmental Interventions. Governmental and quasi-governmental authorities and regulators throughout the world have responded to the outbreak and the resulting economic disruptions with a variety of fiscal and monetary policy changes, including direct capital infusions into companies and other issuers, new monetary policy tools, and lower interest rates. An unexpected or sudden reversal of these policies, or the ineffectiveness of such policies, is likely to increase market volatility, which could adversely affect the Fund’s investments. |
■ | Pre-Existing Conditions. Public health crises caused by the outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. |
Approximate Value of a Creation Unit |
Creation Unit Size |
Standard Creation/ Redemption Transaction Fee |
Maximum Additional Charge for Creations* |
Maximum Additional Charge for Redemptions* |
||||
$2,514,000 | 100,000 | $900 | 3.0% | 2.0% |
* | As a percentage of the net asset value per Creation Unit, inclusive, in the case of redemptions, of the standard redemption transaction fee. |
iShares iBonds 2024 Term High Yield and Income ETF | |
Period From 05/07/19(a) to 10/31/19 |
|
Net asset value, beginning of period | $25.00 |
Net investment income(b) | 0.68 |
Net realized and unrealized gain(c) | 0.09 |
Net increase from investment operations | 0.77 |
Distributions(d) | |
From net investment income | (0.56) |
Total distributions | (0.56) |
Net asset value, end of period | $25.21 |
Total Return | |
Based on net asset value | 3.08%(e) |
Ratios to Average Net Assets | |
Total expenses | 0.35%(f) |
Net investment income | 5.55%(f) |
Supplemental Data | |
Net assets, end of period (000) | $12,604 |
Portfolio turnover rate(g) | 10%(e) |
(a) Commencement of operations. |
|
(b) Based on average shares outstanding. | |
(c) The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities. | |
(d) Distributions for annual periods determined in accordance with U.S. federal income tax regulations. | |
(e) Not annualized. | |
(f) Annualized. | |
(g) Portfolio turnover rate excludes in-kind transactions. |
Premium/Discount Range | Number of Days | Percentage of Total Days | ||
Greater than 0.5% and Less than 1.0% | 7 | 4.27% | ||
Greater than 0.0% and Less than 0.5% | 142 | 86.58 | ||
At NAV | 1 | 0.61 | ||
Less than 0.0% and Greater than -0.5% | 13 | 7.93 | ||
Less than -1.0% and Greater than -1.5% | 1 | 0.61 | ||
164 | 100.00% |
Cumulative Total Returns | ||
Since Inception |
||
Fund NAV | 3.08% | |
Fund Market | 3.04 | |
Index | 2.95 |
Total returns for the period since inception are calculated from the inception date of the Fund (5/7/19). The first day of secondary market trading in shares of the Fund was 5/9/19. |
Call: | 1-800-iShares or 1-800-474-2737 (toll free) Monday through Friday, 8:30 a.m. to 6:30 p.m. (Eastern time) |
Email: | iSharesETFs@blackrock.com |
Write: | c/o BlackRock Investments, LLC 1 University Square Drive, Princeton, NJ 08540 |
February 28, 2020 | |
(as revised June 30, 2020) |
2020 Prospectus |
• | iShares iBonds 2025 Term High Yield and Income ETF* | IBHE | CBOE BZX |
|
S-1 |
|
1 |
|
2 |
|
15 |
|
22 |
|
22 |
|
25 |
|
33 |
|
34 |
|
35 |
|
35 |
|
38 |
Ticker: IBHE | Stock Exchange: Cboe BZX |
Annual Fund Operating Expenses (ongoing expenses that you pay each year as a percentage of the value of your investments) |
||||||||||||
Management Fees |
Distribution and Service (12b-1) Fees |
Other Expenses1 |
Acquired Fund Fees and Expenses1,2 |
Total Annual Fund Operating Expenses |
Fee Waiver1,2 | Total Annual Fund Operating Expenses After Fee Waiver |
||||||
0.35% | None | 0.00% | 0.00% | 0.35% | (0.00)% | 0.35% |
1 | The amount rounded to 0.00%. |
2 | BFA, the investment adviser to the Fund, has contractually agreed to waive a portion of its management fees in an amount equal to the Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its affiliates through the termination date of the Fund, on or about December 15, 2025. The contractual waiver may be terminated prior to the Fund's termination only upon the written agreement of the Trust and BFA. |
1 Year | 3 Years | |||
$36 | $113 |
■ | High yield securities may be issued by less creditworthy issuers. Issuers of high yield securities may have a larger amount of outstanding debt relative to their assets than issuers of investment-grade bonds. In the event of an issuer’s bankruptcy, claims of other creditors may have priority over the claims of high yield securities holders, leaving few or no assets available to repay high yield securities holders. |
■ | Prices of high yield securities are subject to extreme price fluctuations. Adverse changes in an issuer’s industry and general economic conditions may have a greater impact on the prices of high yield securities than on other higher rated fixed-income securities. The credit rating of a high yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer. |
■ | Issuers of high yield securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing. |
■ | High yield securities frequently have redemption features that permit an issuer to repurchase the security from the Fund before it matures. If the issuer redeems high yield securities held by the Fund, the Fund may have to invest the proceeds in bonds with lower yields and may lose income. Such use of proceeds will occur when the Fund invests in BBB-rated bonds from the Corporate Index. |
■ | High yield securities may be less liquid than higher rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the high yield securities market, and there may be significant differences in the prices quoted for high yield securities by the dealers. Because high yield securities may be less liquid than higher rated fixed-income securities, judgment may play a greater role in valuing certain of the Fund's securities than is the case with securities trading in a more liquid market. |
■ | The Fund may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer. |
■ | General Impact. This outbreak has resulted in travel restrictions, closed international borders, enhanced health screenings at ports of entry and elsewhere, disruption of |
and delays in healthcare service preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions, lower consumer demand, temporary closures of stores, restaurants and other commercial establishments, layoffs, defaults and other significant economic impacts, as well as general concern and uncertainty. | |
■ | Market Volatility. The outbreak has also resulted in extreme volatility, severe losses, and disruptions in markets which can adversely impact the Fund and its investments, including impairing hedging activity to the extent a Fund engages in such activity, as expected correlations between related markets or instruments may no longer apply. In addition, to the extent the Fund invests in short-term instruments that have negative yields, the Fund’s value may be impaired as a result. Certain issuers of equity securities have cancelled or announced the suspension of dividends. The outbreak has, and may continue to, negatively affect the credit ratings of some fixed income securities and their issuers. |
■ | Market Closures. Certain local markets have been or may be subject to closures, and there can be no assurance that trading will continue in any local markets in which the Fund may invest, when any resumption of trading will occur or, once such markets resume trading, whether they will face further closures. Any suspension of trading in markets in which the Fund invests will have an impact on the Fund and its investments and will impact the Fund’s ability to purchase or sell securities in such markets. |
■ | Operational Risk. The outbreak could also impair the information technology and other operational systems upon which the Fund’s service providers, including BFA, rely, and could otherwise disrupt the ability of employees of the Fund’s service providers to perform critical tasks relating to the Fund, for example, due to the service providers’ employees performing tasks in alternate locations than under normal operating conditions or the illness of certain employees of the Fund’s service providers. |
■ | Governmental Interventions. Governmental and quasi-governmental authorities and regulators throughout the world have responded to the outbreak and the resulting economic disruptions with a variety of fiscal and monetary policy changes, including direct capital infusions into companies and other issuers, new monetary policy tools, and lower interest rates. An unexpected or sudden reversal of these policies, or the ineffectiveness of such policies, is likely to increase market volatility, which could adversely affect the Fund’s investments. |
■ | Pre-Existing Conditions. Public health crises caused by the outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. |
Approximate Value of a Creation Unit |
Creation Unit Size |
Standard Creation/ Redemption Transaction Fee |
Maximum Additional Charge for Creations* |
Maximum Additional Charge for Redemptions* |
||||
$2,515,000 | 100,000 | $975 | 3.0% | 2.0% |
* | As a percentage of the net asset value per Creation Unit, inclusive, in the case of redemptions, of the standard redemption transaction fee. |
iShares iBonds 2025 Term High Yield and Income ETF | |
Period From 05/07/19(a) to 10/31/19 |
|
Net asset value, beginning of period | $25.00 |
Net investment income(b) | 0.71 |
Net realized and unrealized gain(c) | 0.00(d) |
Net increase from investment operations | 0.71 |
Distributions(e) | |
From net investment income | (0.58) |
Total distributions | (0.58) |
Net asset value, end of period | $25.13 |
Total Return | |
Based on net asset value | 2.87%(f) |
Ratios to Average Net Assets | |
Total expenses | 0.35%(g) |
Net investment income | 5.84%(g) |
Supplemental Data | |
Net assets, end of period (000) | $12,565 |
Portfolio turnover rate(h) | 5%(f) |
(a) Commencement of operations. |
|
(b) Based on average shares outstanding. | |
(c) The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities. | |
(d) Rounds to less than $0.01. | |
(e) Distributions for annual periods determined in accordance with U.S. federal income tax regulations. | |
(f) Not annualized. | |
(g) Annualized. | |
(h) Portfolio turnover rate excludes in-kind transactions. |
Premium/Discount Range | Number of Days | Percentage of Total Days | ||
Greater than 0.5% and Less than 1.0% | 7 | 4.27% | ||
Greater than 0.0% and Less than 0.5% | 145 | 88.41 | ||
At NAV | 1 | 0.61 | ||
Less than 0.0% and Greater than -0.5% | 11 | 6.71 | ||
164 | 100.00% |
Cumulative Total Returns | ||
Since Inception |
||
Fund NAV | 2.87% | |
Fund Market | 3.03 | |
Index | 2.94 |
Total returns for the period since inception are calculated from the inception date of the Fund (5/7/19). The first day of secondary market trading in shares of the Fund was 5/9/19. |
Call: | 1-800-iShares or 1-800-474-2737 (toll free) Monday through Friday, 8:30 a.m. to 6:30 p.m. (Eastern time) |
Email: | iSharesETFs@blackrock.com |
Write: | c/o BlackRock Investments, LLC 1 University Square Drive, Princeton, NJ 08540 |
Fund | Ticker | Listing Exchange | ||
iShares iBonds 2021 Term High Yield and Income ETF1 | IBHA | Cboe BZX | ||
iShares iBonds 2022 Term High Yield and Income ETF2 | IBHB | Cboe BZX | ||
iShares iBonds 2023 Term High Yield and Income ETF3 | IBHC | Cboe BZX | ||
iShares iBonds 2024 Term High Yield and Income ETF4 | IBHD | Cboe BZX | ||
iShares iBonds 2025 Term High Yield and Income ETF5 | IBHE | Cboe BZX | ||
iShares iBonds Dec 2020 Term Corporate ETF6 | IBDL | NYSE Arca | ||
iShares iBonds Dec 2021 Term Corporate ETF7 | IBDM | NYSE Arca | ||
iShares iBonds Dec 2022 Term Corporate ETF8 | IBDN | NYSE Arca | ||
iShares iBonds Dec 2023 Term Corporate ETF9 | IBDO | NYSE Arca | ||
iShares iBonds Dec 2024 Term Corporate ETF10 | IBDP | NYSE Arca | ||
iShares iBonds Dec 2025 Term Corporate ETF11 | IBDQ | NYSE Arca | ||
iShares iBonds Dec 2026 Term Corporate ETF12 | IBDR | NYSE Arca | ||
iShares iBonds Dec 2027 Term Corporate ETF13 | IBDS | NYSE Arca | ||
iShares iBonds Dec 2028 Term Corporate ETF14 | IBDT | NYSE Arca | ||
iShares iBonds Dec 2029 Term Corporate ETF15 | IBDU | NYSE Arca | ||
iShares iBonds Mar 2023 Term Corporate ETF16 | IBDD | NYSE Arca |
4 | The iShares iBonds 2024 Term High Yield and Income ETF may also conduct business as the iBonds 2024 Term High Yield and Income ETF. |
5 | The iShares iBonds 2025 Term High Yield and Income ETF may also conduct business as the iBonds 2025 Term High Yield and Income ETF. |
6 | The iShares iBonds Dec 2020 Term Corporate ETF may also conduct business as the iBonds Dec 2020 Term Corporate ETF. |
7 | The iShares iBonds Dec 2021 Term Corporate ETF may also conduct business as the iBonds Dec 2021 Term Corporate ETF. |
8 | The iShares iBonds Dec 2022 Term Corporate ETF may also conduct business as the iBonds Dec 2022 Term Corporate ETF. |
9 | The iShares iBonds Dec 2023 Term Corporate ETF may also conduct business as the iBonds Dec 2023 Term Corporate ETF. |
10 | The iShares iBonds Dec 2024 Term Corporate ETF may also conduct business as the iBonds Dec 2024 Term Corporate ETF. |
11 | The iShares iBonds Dec 2025 Term Corporate ETF may also conduct business as the iBonds Dec 2025 Term Corporate ETF. |
12 | The iShares iBonds Dec 2026 Term Corporate ETF may also conduct business as the iBonds Dec 2026 Term Corporate ETF. |
13 | The iShares iBonds Dec 2027 Term Corporate ETF may also conduct business as the iBonds Dec 2027 Term Corporate ETF. |
14 | The iShares iBonds Dec 2028 Term Corporate ETF may also conduct business as the iBonds Dec 2028 Term Corporate ETF. |
15 | The iShares iBonds Dec 2029 Term Corporate ETF may also conduct business as the iBonds Dec 2029 Term Corporate ETF. |
16 |
• | iShares iBonds 2021 Term High Yield and Income ETF |
• | iShares iBonds 2022 Term High Yield and Income ETF |
• | iShares iBonds 2023 Term High Yield and Income ETF |
• | iShares iBonds 2024 Term High Yield and Income ETF |
• | iShares iBonds 2025 Term High Yield and Income ETF |
• | iShares iBonds Dec 2020 Term Corporate ETF |
• | iShares iBonds Dec 2021 Term Corporate ETF |
• | iShares iBonds Dec 2022 Term Corporate ETF |
• | iShares iBonds Dec 2023 Term Corporate ETF |
• | iShares iBonds Dec 2024 Term Corporate ETF |
• | iShares iBonds Dec 2025 Term Corporate ETF |
• | iShares iBonds Dec 2026 Term Corporate ETF |
• | iShares iBonds Dec 2027 Term Corporate ETF |
• | iShares iBonds Dec 2028 Term Corporate ETF |
• | iShares iBonds Dec 2029 Term Corporate ETF |
• | iShares iBonds Mar 2023 Term Corporate ETF |
Diversified Funds | Non-Diversified Funds | |
iShares iBonds Dec 2020 Term Corporate ETF | iShares iBonds 2021 Term High Yield and Income ETF | |
iShares iBonds Dec 2021 Term Corporate ETF | iShares iBonds 2022 Term High Yield and Income ETF | |
iShares iBonds Dec 2022 Term Corporate ETF | iShares iBonds 2023 Term High Yield and Income ETF | |
iShares iBonds Dec 2023 Term Corporate ETF | iShares iBonds 2024 Term High Yield and Income ETF | |
iShares iBonds Dec 2024 Term Corporate ETF | iShares iBonds 2025 Term High Yield and Income ETF | |
iShares iBonds Dec 2025 Term Corporate ETF | iShares iBonds Dec 2027 Term Corporate ETF | |
iShares iBonds Dec 2026 Term Corporate ETF | iShares iBonds Dec 2028 Term Corporate ETF | |
iShares iBonds Mar 2023 Term Corporate ETF | iShares iBonds Dec 2029 Term Corporate ETF |
• | High yield bonds may be issued by less creditworthy issuers. These securities are vulnerable to adverse changes in the issuer’s industry or to general economic conditions. Issuers of high yield bonds may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments or the unavailability of additional financing. |
• | The issuers of high yield bonds may have a larger amount of outstanding debt relative to their assets than issuers of investment grade bonds. If the issuer experiences financial stress, it may be unable to meet its debt obligations. The issuer’s ability to pay its debt obligations also may be lessened by specific issuer developments, or the unavailability of additional financing. Issuers of high yield securities are often in the growth stage of their development and/or involved in a reorganization or takeover. |
• | High yield bonds are frequently ranked junior to claims by other creditors. If the issuer cannot meet its obligations, the senior obligations are generally paid off before the junior obligations, which will potentially limit a Fund’s ability to fully recover principal, to receive interest payments when senior securities are in default or to receive restructuring benefits paid to holders of more senior classes of debt. Thus, investors in high yield securities frequently have a lower degree of protection with respect to principal and interest payments than do investors in higher rated securities. |
• | High yield bonds frequently have redemption features that permit an issuer to repurchase the security from a Fund before it matures. If an issuer redeems the high yield bonds, a Fund may have to invest the proceeds in bonds with lower yields and may lose income. Such use of proceeds will occur when a Fund invests in BBB-rated bonds from the Bloomberg Barclays U.S. Corporate Index (the “Corporate Index”). |
• | Prices of high yield bonds are subject to extreme fluctuations. Negative economic developments may have a greater impact on the prices of high yield bonds than on those of other higher rated fixed-income securities. |
• | The secondary markets for high yield securities are not as liquid as the secondary markets for higher rated securities. The secondary markets for high yield securities are concentrated in relatively few market makers and, participants in the markets are mostly institutional investors, including insurance companies, banks, other financial institutions and mutual funds. In addition, the trading volume for high yield securities is generally lower than that for higher rated securities and the secondary markets could contract under adverse market or economic conditions independent of any specific adverse changes in the condition of a particular issuer. Under certain economic and/or market conditions, a Fund may have difficulty disposing of certain high yield securities due to the limited number of investors in that sector of the market. An illiquid secondary market may adversely affect the market price of the high yield security, which may result in increased difficulty selling the particular issue and obtaining accurate market quotations on the issue when valuing a Fund's assets. Market quotations on high yield securities are available only from a limited number of dealers, and such quotations may not be the actual prices available for a purchase or sale. When the secondary market for high yield securities becomes more illiquid, or in the absence of readily available market quotations for such securities, the relative lack of reliable objective data makes it more difficult to value such securities, and judgment plays a more important role in determining such valuations. |
• | A Fund may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer. |
• | The high yield bond markets may react strongly to adverse news about an issuer or the economy, or to the |
perception or expectation of adverse news, whether or not it is based on fundamental analysis. Additionally, prices for high yield securities may be affected by legislative and regulatory developments. These developments could adversely affect a Fund’s net asset value and investment practices, the secondary market for high yield securities, the financial condition of issuers of these securities and the value and liquidity of outstanding high yield securities, especially in a thinly traded market. For example, federal legislation requiring the divestiture by federally insured savings and loan associations of their investments in high yield bonds and limiting the deductibility of interest by certain corporate issuers of high yield bonds adversely affected the market in the past. |
1. | Concentrate its investments in a particular industry, as that term is used in the Investment Company Act, except that the Fund will concentrate to approximately the same extent that its Underlying Index concentrates in the securities of a particular industry or group of industries. |
2. | Borrow money, except as permitted under the Investment Company Act. |
3. | Issue senior securities to the extent such issuance would violate the Investment Company Act. |
4. | Purchase or hold real estate, except the Fund may purchase and hold securities or other instruments that are secured by, or linked to, real estate or interests therein, securities of REITs, mortgage-related securities and securities of issuers engaged in the real estate business, and the Fund may purchase and hold real estate as a result of the ownership of securities or other instruments. |
5. | Underwrite securities issued by others, except to the extent that the sale of portfolio securities by the Fund may be deemed to be an underwriting or as otherwise permitted by applicable law. |
6. | Purchase or sell commodities or commodity contracts, except as permitted by the Investment Company Act. |
7. | Make loans to the extent prohibited by the Investment Company Act. |
Name (Age) | Position | Principal Occupation(s) During the Past 5 Years |
Other Directorships Held by Trustee |
|||
Robert S. Kapito1 (63) |
Trustee (since 2009). |
President, BlackRock, Inc. (since 2006); Vice Chairman of BlackRock, Inc. and Head of BlackRock’s Portfolio Management Group (since its formation in 1998) and BlackRock, Inc.’s predecessor entities (since 1988); Trustee, University of Pennsylvania (since 2009); President of Board of Directors, Hope & Heroes Children’s Cancer Fund (since 2002). | Director of BlackRock, Inc. (since 2006); Director of iShares, Inc. (since 2009); Trustee of iShares U.S. ETF Trust (since 2011). | |||
Salim Ramji2 (49) |
Trustee (since 2019). | Senior Managing Director, BlackRock, Inc. (since 2014); Global Head of BlackRock’s ETF and Index Investments Business (since 2019); Head of BlackRock’s U.S. Wealth Advisory Business (2015-2019); Global Head of Corporate Strategy, BlackRock, Inc. (2014-2015); Senior Partner, McKinsey & Company (2010-2014). | Director of iShares, Inc. (since 2019); Trustee of iShares U.S. ETF Trust (since 2019). |
1 | Robert S. Kapito is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its affiliates. |
2 | Salim Ramji is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its affiliates. |
Name (Age) | Position | Principal Occupation(s) During the Past 5 Years |
Other Directorships Held by Trustee |
|||
Cecilia H. Herbert (70) |
Trustee (since 2005); Independent Board Chair (since 2016). |
Chair of the Finance Committee (since 2019) and Trustee and Member of the Finance, Audit and Quality Committees of Stanford Health Care (since 2016); Trustee of
WNET, New York's public media company (since 2011) and Member of the Audit Committee (since 2018) and Investment Committee (since 2011); Chair (1994-2005) and Member (since 1992) of the Investment Committee,
Archdiocese of San Francisco; Trustee of Forward Funds (14 portfolios) (2009-2018); Trustee of Salient MF Trust (4 portfolios) (2015-2018); Director (1998-2013) and President (2007-2011) of the Board of Directors,
Catholic Charities CYO; Trustee (2002-2011) and Chair of the Finance and Investment Committee (2006-2010) of the Thacher School.
|
Director of iShares, Inc. (since 2005); Trustee of iShares U.S. ETF Trust (since 2011); Independent Board Chair of iShares, Inc. and iShares U.S. ETF Trust (since 2016); Trustee of Thrivent Church Loan and Income Fund (since 2019). | |||
Jane D. Carlin (64) |
Trustee (since 2015); Risk Committee Chair (since 2016). |
Consultant (since 2012); Member of the Audit Committee (2012-2018), Chair of the Nominating and Governance Committee (2017-2018) and Director of PHH Corporation (mortgage solutions) (2012-2018); Managing Director and Global Head of Financial Holding Company Governance & Assurance and the Global Head of Operational Risk Management of Morgan Stanley (2006-2012). | Director of iShares, Inc. (since 2015); Trustee of iShares U.S. ETF Trust (since 2015); Member of the Audit Committee (since 2016) and Director of The Hanover Insurance Group, Inc. (since 2016). | |||
Richard L. Fagnani (65) |
Trustee (since 2017); Audit Committee Chair (since 2019). |
Partner, KPMG LLP (2002-2016). | Director of iShares, Inc. (since 2017); Trustee of iShares U.S. ETF Trust (since 2017). | |||
John E. Kerrigan (64) |
Trustee (since 2005); Nominating and Governance and Equity Plus Committee Chairs (since 2019). |
Chief Investment Officer, Santa Clara University (since 2002). | Director of iShares, Inc. (since 2005); Trustee of iShares U.S. ETF Trust (since 2011). |
Name (Age) | Position | Principal Occupation(s) During the Past 5 Years |
Other Directorships Held by Trustee |
|||
Drew E. Lawton (60) |
Trustee (since 2017); 15(c) Committee Chair (since 2017). |
Senior Managing Director of New York Life Insurance Company (2010-2015). | Director of iShares, Inc. (since 2017); Trustee of iShares U.S. ETF Trust (since 2017). | |||
John E. Martinez (58) |
Trustee (since 2003); Securities Lending Committee Chair (since 2019). |
Director of Real Estate Equity Exchange, Inc. (since 2005); Director of Cloudera Foundation (since 2017); and Director of Reading Partners (2012-2016). | Director of iShares, Inc. (since 2003); Trustee of iShares U.S. ETF Trust (since 2011). | |||
Madhav V. Rajan (55) |
Trustee (since 2011); Fixed Income Plus Committee Chair (since 2019). |
Dean, and George Pratt Shultz Professor of Accounting, University of Chicago Booth School of Business (since 2017); Chair of the Board for the Center for Research in Security Prices, LLC (since 2020); Robert K. Jaedicke Professor of Accounting, Stanford University Graduate School of Business (2001-2017); Professor of Law (by courtesy), Stanford Law School (2005-2017); Senior Associate Dean for Academic Affairs and Head of MBA Program, Stanford University Graduate School of Business (2010-2016). | Director of iShares, Inc. (since 2011); Trustee of iShares U.S. ETF Trust (since 2011). |
Name (Age) | Position | Principal Occupation(s) During the Past 5 Years |
||
Armando Senra (48) |
President (since 2019). | Managing Director, BlackRock, Inc. (since 2007); Head of U.S., Canada and Latam iShares, BlackRock, Inc. (since 2019); Head of Latin America Region, BlackRock, Inc. (2006-2019); Managing Director, Bank of America Merrill Lynch (1994-2006). | ||
Trent Walker (45) |
Treasurer and Chief Financial Officer (since 2020). |
Managing Director of BlackRock, Inc. (since September 2019); Executive Vice President of PIMCO (2016-2019); Senior Vice President of PIMCO (2008-2015); Treasurer (2013-2019) and Assistant Treasurer (2007-2017) of PIMCO Funds, PIMCO Variable Insurance Trust, PIMCO ETF Trust, PIMCO Equity Series, PIMCO Equity Series VIT, PIMCO Managed Accounts Trust, 2 PIMCO-sponsored interval funds and 21 PIMCO-sponsored closed-end funds. |
Name (Age) | Position | Principal Occupation(s) During the Past 5 Years |
||
Charles Park (52) |
Chief Compliance Officer (since 2006). | Chief Compliance Officer of BlackRock Advisors, LLC and the BlackRock-advised Funds in the Equity-Bond Complex, the Equity-Liquidity Complex and the Closed-End Complex (since 2014); Chief Compliance Officer of BFA (since 2006). | ||
Deepa Damre (44) |
Secretary (since 2019). | Managing Director, BlackRock, Inc. (since 2014); Director, BlackRock, Inc. (2009-2013). | ||
Scott Radell (51) |
Executive Vice President (since 2012). |
Managing Director, BlackRock, Inc. (since 2009); Head of Portfolio Solutions, BlackRock, Inc. (since 2009). | ||
Alan Mason (59) |
Executive Vice President (since 2016). |
Managing Director, BlackRock, Inc. (since 2009). | ||
Marybeth Leithead (57) |
Executive Vice President (since 2019). |
Managing Director, BlackRock, Inc. (since 2017); Chief Operating Officer of Americas iShares (since 2017); Portfolio Manager, Municipal Institutional & Wealth Management (2009-2016). |
Name | Fund | Dollar Range of Equity Securities in Named Fund |
Aggregate Dollar Range of Equity Securities in all Registered Investment Companies Overseen by Trustee in Family of Investment Companies |
|||
Robert S. Kapito | None | None | None | |||
Salim Ramji1 | iShares Commodities Select Strategy ETF | $10,001-$50,000 | Over $100,000 | |||
iShares Core MSCI Emerging Markets ETF | Over $100,000 | |||||
iShares Core MSCI Total International Stock ETF | $1-$10,000 | |||||
iShares Core S&P 500 ETF | $1-$10,000 | |||||
iShares Core S&P Total U.S. Stock Market ETF | $1-$10,000 | |||||
iShares Expanded Tech Sector ETF | $1-$10,000 | |||||
iShares Expanded Tech-Software Sector ETF | $1-$10,000 | |||||
iShares MSCI USA ESG Select ETF | $1-$10,000 | |||||
iShares North American Natural Resources ETF | $10,001-$50,000 | |||||
iShares Robotics and Artificial Intelligence Multisector ETF | $1-$10,000 | |||||
iShares TIPS Bond ETF | $10,001-$50,000 | |||||
Cecilia H. Herbert | iShares California Muni Bond ETF | Over $100,000 | Over $100,000 | |||
iShares China Large-Cap ETF | $50,001-$100,000 | |||||
iShares Core Dividend Growth ETF | $50,001-$100,000 | |||||
iShares Core MSCI Emerging Markets ETF | $1-$10,000 | |||||
iShares Core MSCI Total International Stock ETF | $10,001-$50,000 | |||||
iShares Core S&P 500 ETF | Over $100,000 | |||||
iShares Core S&P U.S. Growth ETF | $50,001-$100,000 | |||||
iShares Core S&P U.S. Value ETF | $50,001-$100,000 | |||||
iShares iBoxx $ High Yield Corporate Bond ETF | $10,001-$50,000 | |||||
iShares International Select Dividend ETF | $1-$10,000 | |||||
iShares MSCI EAFE ETF | $1-$10,000 |
Name | Fund | Dollar Range of Equity Securities in Named Fund |
Aggregate Dollar Range of Equity Securities in all Registered Investment Companies Overseen by Trustee in Family of Investment Companies |
|||
iShares MSCI Japan ETF | $10,001-$50,000 | |||||
iShares National Muni Bond ETF | $10,001-$50,000 | |||||
iShares Preferred and Income Securities ETF | $10,001-$50,000 | |||||
Jane D. Carlin | iShares 1-3 Year Treasury Bond ETF | $50,001-$100,000 | Over $100,000 | |||
iShares Core MSCI Emerging Markets ETF | $10,001-$50,000 | |||||
iShares Core MSCI Total International Stock ETF | Over $100,000 | |||||
iShares Core S&P Mid-Cap ETF | $10,001-$50,000 | |||||
iShares Core S&P Small-Cap ETF | Over $100,000 | |||||
iShares Core U.S. Aggregate Bond ETF | Over $100,000 | |||||
iShares Edge MSCI Min Vol USA ETF | $50,001-$100,000 | |||||
iShares Global Tech ETF | $10,001-$50,000 | |||||
iShares MSCI ACWI ETF | Over $100,000 | |||||
iShares MSCI ACWI ex U.S. ETF | $50,001-$100,000 | |||||
iShares MSCI EAFE Small-Cap ETF | $10,001-$50,000 | |||||
iShares MSCI Emerging Markets Small-Cap ETF | $10,001-$50,000 | |||||
iShares Select Dividend ETF | $10,001-$50,000 | |||||
iShares Ultra Short-Term Bond ETF | Over $100,000 | |||||
Richard L. Fagnani | iShares Core MSCI EAFE ETF | $10,001-$50,000 | Over $100,000 | |||
iShares Core S&P 500 ETF | $10,001-$50,000 | |||||
iShares Core S&P Small-Cap ETF | $10,001-$50,000 | |||||
iShares Edge MSCI Multifactor Emerging Markets ETF | $10,001-$50,000 | |||||
iShares Edge MSCI USA Value Factor ETF | $10,001-$50,000 | |||||
iShares Exponential Technologies ETF | $10,001-$50,000 | |||||
iShares Global Clean Energy ETF | $10,001-$50,000 | |||||
iShares MSCI EAFE Value ETF | $10,001-$50,000 | |||||
iShares MSCI Emerging Markets Small-Cap ETF | $10,001-$50,000 | |||||
iShares Robotics and Artificial Intelligence Multisector ETF | $10,001-$50,000 | |||||
iShares S&P Small-Cap 600 Value ETF | $10,001-$50,000 | |||||
iShares Select Dividend ETF | $10,001-$50,000 | |||||
iShares U.S. Financials ETF | $10,001-$50,000 | |||||
John E. Kerrigan | iShares MSCI ACWI ex U.S. ETF | Over $100,000 | Over $100,000 | |||
Name | Fund | Dollar Range of Equity Securities in Named Fund |
Aggregate Dollar Range of Equity Securities in all Registered Investment Companies Overseen by Trustee in Family of Investment Companies |
|||
Drew E. Lawton | iShares 0-5 Year High Yield Corporate Bond ETF | Over $100,000 | Over $100,000 | |||
iShares Core Dividend Growth ETF | $50,001-$100,000 | |||||
iShares Core MSCI Total International Stock ETF | $50,001-$100,000 | |||||
iShares Core S&P Total U.S. Stock Market ETF | Over $100,000 | |||||
iShares Exponential Technologies ETF | Over $100,000 | |||||
iShares MSCI Frontier 100 ETF | $1-$10,000 | |||||
iShares Nasdaq Biotechnology ETF | $50,001-$100,000 | |||||
iShares Short Maturity Bond ETF | Over $100,000 | |||||
iShares Ultra Short-Term Bond ETF | Over $100,000 | |||||
John E. Martinez | iShares Core 5-10 Year USD Bond ETF | Over $100,000 | Over $100,000 | |||
iShares Core International Aggregate Bond ETF | Over $100,000 | |||||
iShares Global Consumer Staples ETF | Over $100,000 | |||||
iShares Interest Rate Hedged Long-Term Corporate Bond ETF | Over $100,000 | |||||
iShares Intermediate-Term Corporate Bond ETF | Over $100,000 | |||||
iShares MSCI EAFE ETF | Over $100,000 | |||||
iShares Russell 1000 ETF | Over $100,000 | |||||
iShares Russell 1000 Value ETF | Over $100,000 | |||||
iShares Russell 2000 ETF | Over $100,000 | |||||
Madhav V. Rajan | iShares Broad USD High Yield Corporate Bond ETF | Over $100,000 | Over $100,000 | |||
iShares Core Dividend Growth ETF | Over $100,000 | |||||
iShares Core High Dividend ETF | Over $100,000 | |||||
iShares Core MSCI EAFE ETF | Over $100,000 | |||||
iShares Core S&P 500 ETF | Over $100,000 | |||||
iShares Mortgage Real Estate ETF | Over $100,000 | |||||
iShares Preferred and Income Securities ETF | Over $100,000 | |||||
iShares Russell 2000 ETF | Over $100,000 | |||||
iShares Select Dividend ETF | Over $100,000 | |||||
iShares Short-Term Corporate Bond ETF | Over $100,000 | |||||
iShares Short Maturity Bond ETF | Over $100,000 | |||||
iShares Ultra Short-Term Bond ETF | Over $100,000 |
1 | Appointed to serve as an Interested Trustee effective June 19, 2019. |
Name | iShares iBonds 2021 Term High Yield and Income ETF4 |
iShares iBonds 2022 Term High Yield and Income ETF4 |
iShares iBonds 2023 Term High Yield and Income ETF4 |
|||
Independent Trustees: | ||||||
Jane D. Carlin | $3 | $2 | $3 | |||
Richard L. Fagnani | 3 | 3 | 3 | |||
Cecilia H. Herbert | 4 | 3 | 4 | |||
Charles A. Hurty1 | 1 | 1 | 1 | |||
John E. Kerrigan | 3 | 3 | 3 | |||
Drew E. Lawton | 3 | 2 | 3 | |||
John E. Martinez | 3 | 2 | 3 | |||
Madhav V. Rajan | 3 | 2 | 3 | |||
Interested Trustees: | ||||||
Robert S. Kapito | $0 | $0 | $0 | |||
Salim Ramji2 | 0 | 0 | 0 | |||
Mark K. Wiedman3 | 0 | 0 | 0 |
Name | iShares iBonds 2024 Term High Yield and Income ETF4 |
iShares iBonds 2025 Term High Yield and Income ETF4 |
iShares iBonds Dec 2020 Term Corporate ETF |
|||
Independent Trustees: | ||||||
Jane D. Carlin | $3 | $3 | $315 | |||
Richard L. Fagnani | 3 | 3 | 324 | |||
Cecilia H. Herbert | 4 | 4 | 361 | |||
Charles A. Hurty1 | 1 | 1 | 101 | |||
John E. Kerrigan | 3 | 3 | 329 | |||
Drew E. Lawton | 3 | 3 | 315 | |||
John E. Martinez | 3 | 3 | 315 | |||
Madhav V. Rajan | 3 | 3 | 315 | |||
Interested Trustees: | ||||||
Robert S. Kapito | $0 | $0 | $0 | |||
Salim Ramji2 | 0 | 0 | 0 | |||
Mark K. Wiedman3 | 0 | 0 | 0 |
Name | iShares iBonds Dec 2021 Term Corporate ETF |
iShares iBonds Dec 2022 Term Corporate ETF |
iShares iBonds Dec 2023 Term Corporate ETF |
|||
Independent Trustees: | ||||||
Jane D. Carlin | $334 | $263 | $219 | |||
Richard L. Fagnani | 342 | 270 | 225 | |||
Cecilia H. Herbert | 382 | 301 | 251 | |||
Charles A. Hurty1 | 107 | 84 | 70 | |||
John E. Kerrigan | 348 | 274 | 229 | |||
Drew E. Lawton | 334 | 263 | 219 | |||
John E. Martinez | 334 | 263 | 219 | |||
Madhav V. Rajan | 334 | 263 | 219 | |||
Interested Trustees: | ||||||
Robert S. Kapito | $0 | $0 | $0 | |||
Salim Ramji2 | 0 | 0 | 0 | |||
Mark K. Wiedman3 | 0 | 0 | 0 |
Name | iShares iBonds Dec 2024 Term Corporate ETF |
iShares iBonds Dec 2025 Term Corporate ETF |
iShares iBonds Dec 2026 Term Corporate ETF |
|||
Independent Trustees: | ||||||
Jane D. Carlin | $164 | $128 | $93 | |||
Richard L. Fagnani | 168 | 131 | 95 | |||
Cecilia H. Herbert | 187 | 147 | 106 | |||
Charles A. Hurty1 | 52 | 41 | 30 | |||
John E. Kerrigan | 171 | 134 | 97 | |||
Drew E. Lawton | 164 | 128 | 93 | |||
John E. Martinez | 164 | 128 | 93 | |||
Madhav V. Rajan | 164 | 128 | 93 | |||
Interested Trustees: | ||||||
Robert S. Kapito | $0 | $0 | $0 | |||
Salim Ramji2 | 0 | 0 | 0 | |||
Mark K. Wiedman3 | 0 | 0 | 0 |
Name | iShares iBonds Dec 2027 Term Corporate ETF |
iShares iBonds Dec 2028 Term Corporate ETF |
iShares iBonds Dec 2029 Term Corporate ETF4 |
|||
Independent Trustees: | ||||||
Jane D. Carlin | $63 | $28 | $5 | |||
Richard L. Fagnani | 65 | 29 | 5 | |||
Cecilia H. Herbert | 72 | 32 | 5 | |||
Charles A. Hurty1 | 20 | 9 | 1 | |||
John E. Kerrigan | 66 | 29 | 5 | |||
Drew E. Lawton | 63 | 28 | 5 | |||
John E. Martinez | 63 | 28 | 5 | |||
Madhav V. Rajan | 63 | 28 | 5 | |||
Interested Trustees: | ||||||
Name | iShares iBonds Dec 2027 Term Corporate ETF |
iShares iBonds Dec 2028 Term Corporate ETF |
iShares iBonds Dec 2029 Term Corporate ETF4 |
|||
Robert S. Kapito | $0 | $0 | $0 | |||
Salim Ramji2 | 0 | 0 | 0 | |||
Mark K. Wiedman3 | 0 | 0 | 0 |
Name | iShares iBonds Mar 2023 Term Corporate ETF |
|
Independent Trustees: | ||
Jane D. Carlin | $20 | |
Richard L. Fagnani | 21 | |
Cecilia H. Herbert | 23 | |
Charles A. Hurty1 | 6 | |
John E. Kerrigan | 21 | |
Drew E. Lawton | 20 | |
John E. Martinez | 20 | |
Madhav V. Rajan | 20 | |
Interested Trustees: | ||
Robert S. Kapito | $0 | |
Salim Ramji2 | 0 | |
Mark K. Wiedman3 | 0 |
Name | Pension or Retirement Benefits Accrued As Part of Trust Expenses5 |
Estimated Annual Benefits Upon Retirement5 |
Total Compensation From the Funds and Fund Complex6 |
|||
Independent Trustees: | ||||||
Jane D. Carlin | Not Applicable | Not Applicable | $395,000 | |||
Richard L. Fagnani | Not Applicable | Not Applicable | 421,764 | |||
Cecilia H. Herbert | Not Applicable | Not Applicable | 450,000 | |||
Charles A. Hurty1 | Not Applicable | Not Applicable | N/A | |||
John E. Kerrigan | Not Applicable | Not Applicable | 420,000 | |||
Drew E. Lawton | Not Applicable | Not Applicable | 406,764 | |||
John E. Martinez | Not Applicable | Not Applicable | 395,000 | |||
Madhav V. Rajan | Not Applicable | Not Applicable | 395,000 | |||
Interested Trustees: | ||||||
Robert S. Kapito | Not Applicable | Not Applicable | $0 | |||
Salim Ramji2 | Not Applicable | Not Applicable | $0 | |||
Mark K. Wiedman3 | Not Applicable | Not Applicable | 0 |
1 | Served as an Independent Trustee through December 31, 2018. |
2 | Appointed to serve as an Interested Trustee effective June 19, 2019. |
3 | Served as an Interested Trustee through June 19, 2019. |
4 | Compensation reported is from the Fund’s inception to October 31, 2019. |
5 | No Trustee or officer is entitled to any pension or retirement benefits from the Trust. |
6 | Also includes compensation for service on the Board of Trustees of iShares U.S. ETF Trust and the Board of Directors of iShares, Inc. |
Fund | Name | Percentage of Ownership |
||
iShares iBonds 2021 Term High Yield and Income ETF | State Street Bank and Trust Company 1776 Heritage Drive North Quincy, MA 02171 |
16.00% | ||
Pershing LLC One Pershing Plaza Jersey City, NJ 07399 |
14.62% | |||
Citibank, N.A. 3800 CitiBank Center Tampa Building B/1st Floor Zone 8 Tampa, FL 33610-9122 |
13.67% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
13.08% | |||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
11.35% | |||
Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
10.48% | |||
Goldman, Sachs & Co. 30 Hudson Street 16th Floor Jersey City, NJ 07302 |
6.47% | |||
iShares iBonds 2022 Term High Yield and Income ETF | State Street Bank and Trust Company 1776 Heritage Drive North Quincy, MA 02171 |
45.00% | ||
Goldman, Sachs & Co. 30 Hudson Street 16th Floor Jersey City, NJ 07302 |
13.64% | |||
Pershing LLC One Pershing Plaza Jersey City, NJ 07399 |
11.13% | |||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
9.04% | |||
Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
5.70% | |||
iShares iBonds 2023 Term High Yield and Income ETF | State Street Bank and Trust Company 1776 Heritage Drive North Quincy, MA 02171 |
38.20% |
Fund | Name | Percentage of Ownership |
||
J.P. Morgan Securities, LLC/JPMC 500 Stanton Christiana Road Newark, DE 19713 |
29.26% | |||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
9.51% | |||
Pershing LLC One Pershing Plaza Jersey City, NJ 07399 |
5.53% | |||
Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
5.28% | |||
iShares iBonds 2024 Term High Yield and Income ETF | State Street Bank and Trust Company 1776 Heritage Drive North Quincy, MA 02171 |
39.20% | ||
Goldman, Sachs & Co. 30 Hudson Street 16th Floor Jersey City, NJ 07302 |
29.06% | |||
J.P. Morgan Securities, LLC/JPMC 500 Stanton Christiana Road Newark, DE 19713 |
24.84% | |||
iShares iBonds 2025 Term High Yield and Income ETF | State Street Bank and Trust Company 1776 Heritage Drive North Quincy, MA 02171 |
40.00% | ||
Goldman, Sachs & Co. 30 Hudson Street 16th Floor Jersey City, NJ 07302 |
25.30% | |||
J.P. Morgan Securities, LLC/JPMC 500 Stanton Christiana Road Newark, DE 19713 |
20.15% | |||
iShares iBonds Dec 2020 Term Corporate ETF | National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
15.93% | ||
Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
12.55% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
11.19% | |||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
7.83% |
Fund | Name | Percentage of Ownership |
||
UBS Financial Services Inc. 1000 Harbor Blvd. Weehawken, NJ 07086 |
7.13% | |||
LPL Financial Corporation 9785 Towne Centre Drive San Diego, CA 92121-1968 |
6.43% | |||
Morgan Stanley Smith Barney LLC One New York Plaza New York, NY 10004 |
5.76% | |||
iShares iBonds Dec 2021 Term Corporate ETF | Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
16.83% | ||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
15.31% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
10.46% | |||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
8.15% | |||
UBS Financial Services Inc. 1000 Harbor Blvd. Weehawken, NJ 07086 |
6.88% | |||
Morgan Stanley Smith Barney LLC One New York Plaza New York, NY 10004 |
5.11% | |||
iShares iBonds Dec 2022 Term Corporate ETF | Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
19.32% | ||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
17.07% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
10.80% | |||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
9.60% | |||
UBS Financial Services Inc. 1000 Harbor Blvd. Weehawken, NJ 07086 |
6.29% | |||
Morgan Stanley Smith Barney LLC One New York Plaza New York, NY 10004 |
5.81% |
Fund | Name | Percentage of Ownership |
||
iShares iBonds Dec 2023 Term Corporate ETF | Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
18.11% | ||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
15.36% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
10.19% | |||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
8.19% | |||
Morgan Stanley Smith Barney LLC One New York Plaza New York, NY 10004 |
5.61% | |||
LPL Financial Corporation 9785 Towne Centre Drive San Diego, CA 92121-1968 |
5.09% | |||
UBS Financial Services Inc. 1000 Harbor Blvd. Weehawken, NJ 07086 |
5.04% | |||
iShares iBonds Dec 2024 Term Corporate ETF | Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
21.10% | ||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
13.86% | |||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
10.37% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
7.29% | |||
Morgan Stanley Smith Barney LLC One New York Plaza New York, NY 10004 |
5.26% | |||
iShares iBonds Dec 2025 Term Corporate ETF | Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
20.26% | ||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
16.60% |
Fund | Name | Percentage of Ownership |
||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
9.94% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
6.28% | |||
Morgan Stanley Smith Barney LLC One New York Plaza New York, NY 10004 |
5.18% | |||
iShares iBonds Dec 2026 Term Corporate ETF | Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
17.64% | ||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
12.17% | |||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
7.45% | |||
Interactive Brokers Retail Equity Clearing 8 Greenwich Office Park Greenwich, CT 06831 |
7.43% | |||
U.S. Bank N.A. 1555 North Rivercenter Dr. Suite 302 Milwaukee, WI 53212 |
5.79% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
5.42% | |||
iShares iBonds Dec 2027 Term Corporate ETF | Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
17.91% | ||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
12.27% | |||
Interactive Brokers Retail Equity Clearing 8 Greenwich Office Park Greenwich, CT 06831 |
11.75% | |||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
8.25% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
6.75% |
Fund | Name | Percentage of Ownership |
||
Stifel, Nicolaus & Company Incorporated 501 N. Broadway St. Louis, MO 63102 |
5.26% | |||
iShares iBonds Dec 2028 Term Corporate ETF | Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
13.72% | ||
Stifel, Nicolaus & Company Incorporated 501 N. Broadway St. Louis, MO 63102 |
11.72% | |||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
11.53% | |||
Interactive Brokers Retail Equity Clearing 8 Greenwich Office Park Greenwich, CT 06831 |
11.11% | |||
Pershing LLC One Pershing Plaza Jersey City, NJ 07399 |
9.35% | |||
Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
8.98% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
6.49% | |||
Raymond, James & Associates, Inc. 880 Carillon Parkway P.O. Box 12749 St. Petersburg, FL 33733 |
5.62% | |||
iShares iBonds Dec 2029 Term Corporate ETF | Stifel, Nicolaus & Company Incorporated 501 N. Broadway St. Louis, MO 63102 |
21.70% | ||
State Street Bank and Trust Company 1776 Heritage Drive North Quincy, MA 02171 |
14.29% | |||
TD Ameritrade Clearing, Inc. 4700 Alliance Gateway Freeway Fort Worth, TX 76177 |
13.93% | |||
Pershing LLC One Pershing Plaza Jersey City, NJ 07399 |
10.82% | |||
Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
7.78% | |||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
7.48% |
Fund | Name | Percentage of Ownership |
||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
6.39% | |||
iShares iBonds Mar 2023 Term Corporate ETF | Morgan Stanley Smith Barney LLC One New York Plaza New York, NY 10004 |
30.39% | ||
Merrill Lynch, Pierce, Fenner & Smith Incorporated - TS Sub 101 Hudson Street 9th Floor Jersey City, NJ 07302-3997 |
11.50% | |||
Pershing LLC One Pershing Plaza Jersey City, NJ 07399 |
8.23% | |||
Stifel, Nicolaus & Company Incorporated 501 N. Broadway St. Louis, MO 63102 |
7.62% | |||
National Financial Services LLC 499 Washington Blvd Jersey City, NJ 07310 |
6.81% | |||
Raymond, James & Associates, Inc. 880 Carillon Parkway P.O. Box 12749 St. Petersburg, FL 33733 |
5.47% | |||
Charles Schwab & Co., Inc. 101 Montgomery Street San Francisco, CA 94014 |
5.14% |
Fund | Management Fee for the Fiscal Year Ended Oct. 31, 2019 |
Fund Inception Date |
Management Fees Paid, Net of Waivers, for Fiscal Year Ended Oct. 31, 2019 |
Management Fees Paid, Net of Waivers, for Fiscal Year Ended Oct. 31, 2018 |
Management Fees Paid, Net of Waivers, for Fiscal Year Ended Oct. 31, 2017 |
|||||
iShares iBonds 2021 Term High Yield and Income ETF1 | 0.35% | 05/07/19 | $20,969 | N/A | N/A | |||||
iShares iBonds 2022 Term High Yield and Income ETF2 | 0.35% | 05/07/19 | 16,843 | N/A | N/A | |||||
iShares iBonds 2023 Term High Yield and Income ETF3 | 0.35% | 05/07/19 | 20,875 | N/A | N/A | |||||
iShares iBonds 2024 Term High Yield and Income ETF4 | 0.35% | 05/07/19 | 21,150 | N/A | N/A | |||||
iShares iBonds 2025 Term High Yield and Income ETF5 | 0.35% | 05/07/19 | 21,060 | N/A | N/A | |||||
iShares iBonds Dec 2020 Term Corporate ETF6 | 0.10% | 12/02/14 | 1,056,362 | $607,971 | $306,530 | |||||
iShares iBonds Dec 2021 Term Corporate ETF7 | 0.10% | 03/10/15 | 1,078,756 | 651,609 | 333,120 | |||||
iShares iBonds Dec 2022 Term Corporate ETF8 | 0.10% | 03/10/15 | 785,339 | 434,461 | 239,784 | |||||
iShares iBonds Dec 2023 Term Corporate ETF9 | 0.10% | 03/11/15 | 665,539 | 365,801 | 147,199 | |||||
iShares iBonds Dec 2024 Term Corporate ETF10 | 0.10% | 03/11/15 | 459,365 | 231,838 | 114,623 | |||||
iShares iBonds Dec 2025 Term Corporate ETF11 | 0.10% | 03/11/15 | 407,883 | 293,673 | 157,363 | |||||
iShares iBonds Dec 2026 Term Corporate ETF12 | 0.10% | 09/13/16 | 248,763 | 116,824 | 31,950 | |||||
iShares iBonds Dec 2027 Term Corporate ETF13 | 0.10% | 09/12/17 | 169,231 | 94,371 | 1,315 | |||||
iShares iBonds Dec 2028 Term Corporate ETF14 | 0.10% | 09/18/18 | 62,181 | 1,950 | N/A | |||||
iShares iBonds Dec 2029 Term Corporate ETF15 | 0.10% | 09/17/19 | 1,511 | N/A | N/A |
Fund | Management Fee for the Fiscal Year Ended Oct. 31, 2019 |
Fund Inception Date |
Management Fees Paid, Net of Waivers, for Fiscal Year Ended Oct. 31, 2019 |
Management Fees Paid, Net of Waivers, for Fiscal Year Ended Oct. 31, 2018 |
Management Fees Paid, Net of Waivers, for Fiscal Year Ended Oct. 31, 2017 |
|||||
iShares iBonds Mar 2023 Term Corporate ETF16 | 0.10% | 07/09/13 | 68,684 | 74,460 | 80,471 |
1 | Effective June 30, 2020, BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2021. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. |
2 | Effective June 30, 2020, BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2022. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. |
3 | Effective June 30, 2020, BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2023. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. |
4 | Effective June 30, 2020, BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2024. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. |
5 | Effective June 30, 2020, BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2025. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. |
6 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2020. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal years ended October 31, 2019, October 31, 2018 and October 31, 2017, BFA waived $21,867, $6,005 and $2,657 of its management fees, respectively. |
7 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2021. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal years ended October 31, 2019, October 31, 2018 and October 31, 2017, BFA waived $5,305, $5,681 and $2,237 of its management fees, respectively. |
8 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2022. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal years ended October 31, 2019, October 31, 2018 and October 31, 2017, BFA waived $4,046, $2,980 and $1,639 of its management fees, respectively. |
9 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2023. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal years ended October 31, 2019, October 31, 2018 and October 31, 2017, BFA waived $2,235, $1,482 and $1,545 of its management fees, respectively. |
10 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2024. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal years ended October 31, 2019, October 31, 2018 and October 31, 2017, BFA waived $1,361, $1,379 and $712 of its management fees, respectively. |
11 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2025. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal years ended October 31, 2019, October 31, 2018 and October 31, 2017, BFA waived $1,963, $1,312 and $818 of its management fees, respectively. |
12 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2026. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal years ended October 31, 2019, October 31, 2018 and October 31, 2017, BFA waived $1,143, $596 and $246 of its management fees, respectively. |
13 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2027. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal years ended October 31, 2019, October 31, 2018 and October 31, 2017, BFA waived $760, $572 and $0 of its management fees, respectively. |
14 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to the Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about |
December 15, 2028. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal year ended October 31, 2019 and October 31, 2018, BFA waived $290 and $14 of its management fees, respectively. | |
15 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to the Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about December 15, 2029. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal year ended October 31, 2019, BFA waived $9 of its management fees. |
16 | BFA has contractually agreed to waive a portion of its management fees in an amount equal to Acquired Fund Fees and Expenses, if any, attributable to investments by the Fund in other funds advised by BFA or its Affiliates through the termination date of the Fund, on or about March 31, 2023. The contractual waiver may be terminated prior to the Fund's termination only upon written agreement of the Trust and BFA. For the fiscal years ended October 31, 2019, October 31, 2018 and October 31, 2017, BFA waived $3,648, $3,359 and $4,036 of its management fees, respectively. |
James Mauro | ||||
Types of Accounts | Number | Total Assets | ||
Registered Investment Companies | 73 | $373,780,000,000 | ||
Other Pooled Investment Vehicles | 30 | 113,803,000,000 | ||
Other Accounts | 27 | 24,100,000,000 |
Scott Radell | ||||
Types of Accounts | Number | Total Assets | ||
Registered Investment Companies | 86 | $389,811,000,000 | ||
Other Pooled Investment Vehicles | 26 | 28,278,000,000 | ||
Other Accounts | 11 | 7,808,000,000 |
James Mauro | ||||
Types of Accounts | Number of Other Accounts with Performance-Based Fees Managed by Portfolio Manager |
Aggregate of Total Assets |
||
Registered Investment Companies | 0 | N/A | ||
Other Pooled Investment Vehicles | 0 | N/A | ||
Other Accounts | 0 | N/A |
Scott Radell | ||||
Types of Accounts | Number of Other Accounts with Performance-Based Fees Managed by Portfolio Manager |
Aggregate of Total Assets |
||
Registered Investment Companies | 0 | N/A | ||
Other Pooled Investment Vehicles | 0 | N/A | ||
Other Accounts | 1 | $747,000,000 |
Fund | Fund Inception Date | Administration, Custody & Transfer Agency Expenses Paid During Fiscal Year Ended Oct. 31, 2019 |
Administration, Custody & Transfer Agency Expenses Paid During Fiscal Year Ended Oct. 31, 2018 |
Administration, Custody & Transfer Agency Expenses Paid During Fiscal Year Ended Oct. 31, 2017 |
||||
iShares iBonds 2021 Term High Yield and Income ETF | 05/07/19 | $9,440 | N/A | N/A | ||||
iShares iBonds 2022 Term High Yield and Income ETF | 05/07/19 | 9,767 | N/A | N/A | ||||
iShares iBonds 2023 Term High Yield and Income ETF | 05/07/19 | 9,906 | N/A | N/A | ||||
iShares iBonds 2024 Term High Yield and Income ETF | 05/07/19 | 9,010 | N/A | N/A | ||||
iShares iBonds 2025 Term High Yield and Income ETF | 05/07/19 | 8,999 | N/A | N/A | ||||
iShares iBonds Dec 2020 Term Corporate ETF | 12/02/14 | 21,610 | 20,236 | 7,026 |
Fund | Fund Inception Date | Administration, Custody & Transfer Agency Expenses Paid During Fiscal Year Ended Oct. 31, 2019 |
Administration, Custody & Transfer Agency Expenses Paid During Fiscal Year Ended Oct. 31, 2018 |
Administration, Custody & Transfer Agency Expenses Paid During Fiscal Year Ended Oct. 31, 2017 |
||||
iShares iBonds Dec 2021 Term Corporate ETF | 03/10/15 | 22,959 | 20,367 | 8,073 | ||||
iShares iBonds Dec 2022 Term Corporate ETF | 03/10/15 | 21,296 | 18,855 | 6,383 | ||||
iShares iBonds Dec 2023 Term Corporate ETF | 03/11/15 | 22,065 | 18,053 | 4,365 | ||||
iShares iBonds Dec 2024 Term Corporate ETF | 03/11/15 | 21,464 | 16,505 | 3,698 | ||||
iShares iBonds Dec 2025 Term Corporate ETF | 03/11/15 | 20,766 | 17,233 | 4,021 | ||||
iShares iBonds Dec 2026 Term Corporate ETF | 09/13/16 | 19,790 | 15,163 | 1,650 | ||||
iShares iBonds Dec 2027 Term Corporate ETF | 09/12/17 | 19,173 | 14,039 | 445 | ||||
iShares iBonds Dec 2028 Term Corporate ETF | 09/18/18 | 18,328 | 2,435 | N/A | ||||
iShares iBonds Dec 2029 Term Corporate ETF | 09/17/19 | 2,793 | N/A | N/A | ||||
iShares iBonds Mar 2023 Term Corporate ETF | 07/09/13 | 17,608 | 15,115 | 2,760 |
Fund | iShares iBonds 2021 Term High Yield and Income ETF |
iShares iBonds 2022 Term High Yield and Income ETF |
iShares iBonds 2023 Term High Yield and Income ETF |
Gross income from securities lending activities |
$9,708 | $7,062 | $18,666 |
Fees and/or compensation for securities lending activities and related services |
Fund | iShares iBonds 2021 Term High Yield and Income ETF |
iShares iBonds 2022 Term High Yield and Income ETF |
iShares iBonds 2023 Term High Yield and Income ETF |
Securities lending income paid to BTC for services as securities lending agent |
987 | 332 | 1,042 |
Cash collateral management expenses not included in securities lending income paid to BTC |
128 | 110 | 298 |
Administrative fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Indemnification fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Rebates (paid to borrowers) |
4,096 | 5,104 | 12,583 |
Other fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Aggregate fees/compensation for securities lending activities |
5,211 | 5,546 | 13,923 |
Net income from securities lending activities |
4,497 | 1,516 | 4,743 |
Fund | iShares iBonds 2024 Term High Yield and Income ETF |
iShares iBonds 2025 Term High Yield and Income ETF |
iShares iBonds Dec 2020 Term Corporate ETF |
Gross income from securities lending activities |
$13,536 | $15,629 | $825,409 |
Fund | iShares iBonds 2024 Term High Yield and Income ETF |
iShares iBonds 2025 Term High Yield and Income ETF |
iShares iBonds Dec 2020 Term Corporate ETF |
Fees and/or compensation for securities lending activities and related services |
|||
Securities lending income paid to BTC for services as securities lending agent |
714 | 924 | 19,419 |
Cash collateral management expenses not included in securities lending income paid to BTC |
213 | 246 | 12,762 |
Administrative fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Indemnification fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Rebates (paid to borrowers) |
9,355 | 10,254 | 700,982 |
Other fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Aggregate fees/compensation for securities lending activities |
10,282 | 11,424 | 733,163 |
Net income from securities lending activities |
3,254 | 4,205 | 92,246 |
Fund | iShares iBonds Dec 2021 Term Corporate ETF |
iShares iBonds Dec 2022 Term Corporate ETF |
iShares iBonds Dec 2023 Term Corporate ETF |
Gross income from securities lending activities |
$1,448,423 | $987,789 | $920,203 |
Fees and/or compensation for securities lending activities and related services |
Fund | iShares iBonds Dec 2021 Term Corporate ETF |
iShares iBonds Dec 2022 Term Corporate ETF |
iShares iBonds Dec 2023 Term Corporate ETF |
Securities lending income paid to BTC for services as securities lending agent |
33,756 | 23,504 | 21,409 |
Cash collateral management expenses not included in securities lending income paid to BTC |
22,339 | 15,386 | 14,310 |
Administrative fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Indemnification fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Rebates (paid to borrowers) |
1,232,880 | 837,993 | 782,596 |
Other fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Aggregate fees/compensation for securities lending activities |
1,288,975 | 876,883 | 818,315 |
Net income from securities lending activities |
159,448 | 110,906 | 101,888 |
Fund | iShares iBonds Dec 2024 Term Corporate ETF |
iShares iBonds Dec 2025 Term Corporate ETF |
iShares iBonds Dec 2026 Term Corporate ETF |
Gross income from securities lending activities |
$705,626 | $534,455 | $459,316 |
Fees and/or compensation for securities lending activities and related services |
|||
Securities lending income paid to BTC for services as securities lending agent |
17,603 | 12,282 | 10,827 |
Fund | iShares iBonds Dec 2024 Term Corporate ETF |
iShares iBonds Dec 2025 Term Corporate ETF |
iShares iBonds Dec 2026 Term Corporate ETF |
Cash collateral management expenses not included in securities lending income paid to BTC |
11,077 | 8,404 | 7,211 |
Administrative fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Indemnification fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Rebates (paid to borrowers) |
593,668 | 455,820 | 390,816 |
Other fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Aggregate fees/compensation for securities lending activities |
622,348 | 476,506 | 408,854 |
Net income from securities lending activities |
83,278 | 57,949 | 50,462 |
Fund | iShares iBonds Dec 2027 Term Corporate ETF |
iShares iBonds Dec 2028 Term Corporate ETF |
iShares iBonds Dec 2029 Term Corporate ETF |
Gross income from securities lending activities |
$426,087 | $115,344 | N/A |
Fees and/or compensation for securities lending activities and related services |
|||
Securities lending income paid to BTC for services as securities lending agent |
15,030 | 2,997 | N/A |
Cash collateral management expenses not included in securities lending income paid to BTC |
6,459 | 1,799 | N/A |
Fund | iShares iBonds Dec 2027 Term Corporate ETF |
iShares iBonds Dec 2028 Term Corporate ETF |
iShares iBonds Dec 2029 Term Corporate ETF |
Administrative fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Indemnification fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Rebates (paid to borrowers) |
334,053 | 96,616 | N/A |
Other fees not included in securities lending income paid to BTC |
N/A | N/A | N/A |
Aggregate fees/compensation for securities lending activities |
355,542 | 101,412 | N/A |
Net income from securities lending activities |
70,545 | 13,932 | N/A |
Fund | iShares iBonds Mar 2023 Term Corporate ETF |
Gross income from securities lending activities |
$71,185 |
Fees and/or compensation for securities lending activities and related services |
|
Securities lending income paid to BTC for services as securities lending agent |
1,755 |
Cash collateral management expenses not included in securities lending income paid to BTC |
1,111 |
Administrative fees not included in securities lending income paid to BTC |
N/A |
Fund | iShares iBonds Mar 2023 Term Corporate ETF |
Indemnification fees not included in securities lending income paid to BTC |
N/A |
Rebates (paid to borrowers) |
59,979 |
Other fees not included in securities lending income paid to BTC |
N/A |
Aggregate fees/compensation for securities lending activities |
62,845 |
Net income from securities lending activities |
8,340 |
Fund | Issuer | Market Value of Investment |
||
iShares iBonds 2021 Term High Yield and Income ETF | Deutsche Bank AG | $102,381 | ||
iShares iBonds Dec 2020 Term Corporate ETF | JPMorgan Chase & Co. | $35,957,293 | ||
Morgan Stanley | 24,190,821 | |||
Goldman Sachs Group Inc. (The) | 23,770,869 | |||
Wells Fargo & Co. | 21,506,850 | |||
Royal Bank of Canada | 15,432,069 | |||
Bank of America Corp. | 17,517,533 | |||
Bank of New York Mellon Corp. (The) | 10,647,637 | |||
Credit Suisse AG | 7,699,018 | |||
iShares iBonds Dec 2021 Term Corporate ETF | JPMorgan Chase & Co. | $30,338,724 | ||
Morgan Stanley | 27,610,082 | |||
Goldman Sachs Group Inc. (The) | 23,612,260 | |||
Deutsche Bank AG | 22,482,394 | |||
Citigroup, Inc. | 19,927,646 | |||
Mitsubishi UFJ Financial Group | 11,975,854 | |||
Bank of New York Mellon Corp. (The) | 11,553,536 | |||
Bank of America Corp. | 10,319,397 | |||
Credit Suisse AG | 4,705,419 | |||
iShares iBonds Dec 2022 Term Corporate ETF | Goldman Sachs Group Inc. (The) | $17,376,216 | ||
Citigroup, Inc. | 16,081,667 | |||
Mitsubishi UFJ Financial Group | 13,812,834 | |||
JPMorgan Chase & Co. | 13,497,020 | |||
Wells Fargo & Co. | 12,866,296 | |||
Morgan Stanley | 11,190,127 | |||
Bank of America Corp. | 6,620,180 | |||
Deutsche Bank AG | 4,163,553 | |||
Bank of New York Mellon Corp. (The) | 4,115,066 | |||
iShares iBonds Dec 2023 Term Corporate ETF | JPMorgan Chase & Co. | $16,851,356 | ||
Wells Fargo & Co. | 16,544,929 | |||
Morgan Stanley | 14,597,294 | |||
Bank of America Corp. | 12,778,992 | |||
Bank of New York Mellon Corp. (The) | 8,274,738 | |||
Goldman Sachs Group Inc. (The) | 8,029,190 | |||
Citigroup, Inc. | 6,502,550 | |||
Barclays PLC | 2,792,038 | |||
iShares iBonds Dec 2024 Term Corporate ETF | Bank of America Corp. | $13,469,380 | ||
JPMorgan Chase & Co. | 11,739,725 | |||
Goldman Sachs Group Inc. (The) | 11,625,872 | |||
Wells Fargo & Co. | 10,551,849 | |||
Morgan Stanley | 9,953,644 | |||
Credit Suisse AG | 5,140,620 | |||
Bank of New York Mellon Corp. (The) | 3,198,075 | |||
Citigroup, Inc. | 2,751,944 |
Fund | Issuer | Market Value of Investment |
||
Barclays PLC | 105,230 | |||
iShares iBonds Dec 2025 Term Corporate ETF | Goldman Sachs Group Inc. (The) | $10,191,552 | ||
Bank of America Corp. | 10,163,101 | |||
Citigroup, Inc. | 9,586,892 | |||
JPMorgan Chase & Co. | 7,868,889 | |||
Morgan Stanley | 7,725,399 | |||
Barclays PLC | 2,828,904 | |||
Bank of New York Mellon Corp. (The) | 2,104,593 | |||
U.S. Bancorp. | 1,410,273 | |||
iShares iBonds Dec 2026 Term Corporate ETF | Citigroup, Inc. | $9,395,434 | ||
JPMorgan Chase & Co. | 9,362,970 | |||
Wells Fargo & Co. | 9,188,985 | |||
Morgan Stanley | 8,869,430 | |||
Bank of America Corp. | 6,604,003 | |||
Goldman Sachs Group Inc. (The) | 4,537,313 | |||
Barclays PLC | 2,471,669 | |||
Bank of New York Mellon Corp. (The) | 1,739,717 | |||
iShares iBonds Dec 2027 Term Corporate ETF | Morgan Stanley | $4,365,711 | ||
Bank of America Corp. | 4,116,767 | |||
Citigroup, Inc. | 3,861,702 | |||
Goldman Sachs Group Inc. (The) | 3,795,707 | |||
JPMorgan Chase & Co. | 3,002,112 | |||
Wells Fargo & Co. | 2,517,913 | |||
Bank of New York Mellon Corp. (The) | 765,482 | |||
iShares iBonds Dec 2028 Term Corporate ETF | Citigroup, Inc. | $1,144,686 | ||
Bank of New York Mellon Corp. (The) | 1,020,019 | |||
Barclays PLC | 636,669 | |||
iShares iBonds Dec 2029 Term Corporate ETF | Wells Fargo & Co. | $299,856 | ||
U.S. Bancorp | 155,466 | |||
Bank of New York Mellon Corp. (The) | 73,956 | |||
iShares iBonds Mar 2023 Term Corporate ETF | Morgan Stanley | $1,813,554 | ||
Wells Fargo & Co. | 1,641,305 | |||
JPMorgan Chase & Co. | 1,223,701 | |||
Goldman Sachs Group Inc. (The) | 1,143,543 | |||
Bank of America Corp. | 1,035,990 | |||
Mitsubishi UFJ Financial Group, Inc. | 867,107 | |||
Citigroup, Inc. | 825,404 | |||
Bank of New York Mellon Corp. (The) | 257,495 | |||
Royal Bank of Canada | 204,076 | |||
Fund | Fiscal Year Ended Oct. 31, 2019 |
Fiscal Year Ended Oct. 31, 2018 |
||
iShares iBonds 2021 Term High Yield and Income ETF | 17% | N/A | ||
iShares iBonds 2022 Term High Yield and Income ETF | 14% | N/A | ||
iShares iBonds 2023 Term High Yield and Income ETF | 9% | N/A | ||
iShares iBonds 2024 Term High Yield and Income ETF | 10% | N/A | ||
iShares iBonds 2025 Term High Yield and Income ETF | 5% | N/A | ||
iShares iBonds Dec 2020 Term Corporate ETF | 8% | 5% | ||
iShares iBonds Dec 2021 Term Corporate ETF | 8% | 6% | ||
iShares iBonds Dec 2022 Term Corporate ETF | 9% | 2% | ||
iShares iBonds Dec 2023 Term Corporate ETF | 5% | 8% | ||
iShares iBonds Dec 2024 Term Corporate ETF | 14% | 6% | ||
iShares iBonds Dec 2025 Term Corporate ETF | 6% | 5% | ||
iShares iBonds Dec 2026 Term Corporate ETF | 9% | 3% | ||
iShares iBonds Dec 2027 Term Corporate ETF | 4% | 5% | ||
iShares iBonds Dec 2028 Term Corporate ETF | 6% | 0% | ||
iShares iBonds Dec 2029 Term Corporate ETF | 1% | N/A | ||
iShares iBonds Mar 2023 Term Corporate ETF | 5% | 3% |
Fund | Shares Per Creation Unit |
Approximate Value Per Creation Unit (U.S.$) |
||
iShares iBonds 2021 Term High Yield and Income ETF | 100,000 | $ 2,489,000 | ||
iShares iBonds 2022 Term High Yield and Income ETF | 100,000 | 2,457,000 | ||
iShares iBonds 2023 Term High Yield and Income ETF | 100,000 | 2,468,000 | ||
iShares iBonds 2024 Term High Yield and Income ETF | 100,000 | 2,514,000 | ||
iShares iBonds 2025 Term High Yield and Income ETF | 100,000 | 2,515,000 | ||
iShares iBonds Dec 2020 Term Corporate ETF | 100,000 | 2,532,000 | ||
iShares iBonds Dec 2021 Term Corporate ETF | 100,000 | 2,495,000 | ||
iShares iBonds Dec 2022 Term Corporate ETF | 100,000 | 2,529,000 | ||
iShares iBonds Dec 2023 Term Corporate ETF | 50,000 | 1,276,500 | ||
iShares iBonds Dec 2024 Term Corporate ETF | 50,000 | 1,281,500 | ||
iShares iBonds Dec 2025 Term Corporate ETF | 50,000 | 1,292,500 | ||
iShares iBonds Dec 2026 Term Corporate ETF | 50,000 | 1,272,500 | ||
iShares iBonds Dec 2027 Term Corporate ETF | 50,000 | 1,295,000 | ||
iShares iBonds Dec 2028 Term Corporate ETF | 50,000 | 1,385,000 | ||
iShares iBonds Dec 2029 Term Corporate ETF | 50,000 | 1,272,000 | ||
iShares iBonds Mar 2023 Term Corporate ETF | 50,000 | 1,342,000 |
Fund | Standard Creation Transaction Fee |
Maximum Additional Charge for Creations* |
||
iShares iBonds 2021 Term High Yield and Income ETF | $650 | 3.0% | ||
iShares iBonds 2022 Term High Yield and Income ETF | 825 | 3.0% | ||
iShares iBonds 2023 Term High Yield and Income ETF | 925 | 3.0% | ||
iShares iBonds 2024 Term High Yield and Income ETF | 900 | 3.0% | ||
iShares iBonds 2025 Term High Yield and Income ETF | 975 | 3.0% | ||
iShares iBonds Dec 2020 Term Corporate ETF | 350 | 3.0% | ||
iShares iBonds Dec 2021 Term Corporate ETF | 375 | 3.0% | ||
iShares iBonds Dec 2022 Term Corporate ETF | 625 | 3.0% | ||
iShares iBonds Dec 2023 Term Corporate ETF | 600 | 3.0% | ||
iShares iBonds Dec 2024 Term Corporate ETF | 600 | 3.0% | ||
iShares iBonds Dec 2025 Term Corporate ETF | 250 | 3.0% | ||
iShares iBonds Dec 2026 Term Corporate ETF | 375 | 3.0% | ||
iShares iBonds Dec 2027 Term Corporate ETF | 300 | 3.0% | ||
iShares iBonds Dec 2028 Term Corporate ETF | 650 | 3.0% | ||
iShares iBonds Dec 2029 Term Corporate ETF | 350 | 3.0% | ||
iShares iBonds Mar 2023 Term Corporate ETF | 150 | 3.0% |
* | As a percentage of the net asset value per Creation Unit. |
Fund | Standard Redemption Transaction Fee |
Maximum Additional Charge for Redemptions* |
||
iShares iBonds 2021 Term High Yield and Income ETF | $650 | 2.0% | ||
iShares iBonds 2022 Term High Yield and Income ETF | 825 | 2.0% | ||
iShares iBonds 2023 Term High Yield and Income ETF | 925 | 2.0% | ||
iShares iBonds 2024 Term High Yield and Income ETF | 900 | 2.0% | ||
iShares iBonds 2025 Term High Yield and Income ETF | 975 | 2.0% | ||
iShares iBonds Dec 2020 Term Corporate ETF | 350 | 2.0% | ||
iShares iBonds Dec 2021 Term Corporate ETF | 375 | 2.0% | ||
iShares iBonds Dec 2022 Term Corporate ETF | 625 | 2.0% | ||
iShares iBonds Dec 2023 Term Corporate ETF | 600 | 2.0% | ||
iShares iBonds Dec 2024 Term Corporate ETF | 600 | 2.0% | ||
iShares iBonds Dec 2025 Term Corporate ETF | 250 | 2.0% | ||
iShares iBonds Dec 2026 Term Corporate ETF | 375 | 2.0% | ||
iShares iBonds Dec 2027 Term Corporate ETF | 300 | 2.0% | ||
iShares iBonds Dec 2028 Term Corporate ETF | 650 | 2.0% | ||
iShares iBonds Dec 2029 Term Corporate ETF | 350 | 2.0% | ||
iShares iBonds Mar 2023 Term Corporate ETF | 150 | 2.0% |
* | As a percentage of the net asset value per Creation Unit, inclusive of the standard redemption transaction fee. |
Fund | Net Capital Loss Carryforward | |
iShares iBonds 2021 Term High Yield and Income ETF | $7,262 | |
iShares iBonds 2022 Term High Yield and Income ETF | 147,628 | |
iShares iBonds 2023 Term High Yield and Income ETF | 134,653 | |
iShares iBonds 2024 Term High Yield and Income ETF | 82,670 | |
iShares iBonds 2025 Term High Yield and Income ETF | 74,310 | |
iShares iBonds Dec 2020 Term Corporate ETF | 42,503 | |
iShares iBonds Dec 2021 Term Corporate ETF | 126,448 | |
iShares iBonds Dec 2023 Term Corporate ETF | 958,210 | |
iShares iBonds Dec 2024 Term Corporate ETF | 350,448 | |
iShares iBonds Dec 2025 Term Corporate ETF | 671,433 |
Fund | Net Capital Loss Carryforward | |
iShares iBonds Dec 2026 Term Corporate ETF | 238,681 | |
iShares iBonds Dec 2027 Term Corporate ETF | 33,146 | |
iShares iBonds Mar 2023 Term Corporate ETF | 578,244 |
• | Boards and directors |
• | Auditors and audit-related issues |
• | Capital structure, mergers, asset sales and other special transactions |
• | Compensation and benefits |
• | Environmental and social issues |
• | General corporate governance matters and shareholder protections |
• | establishing an appropriate corporate governance structure |
• | supporting and overseeing management in setting long -term strategic goals, applicable measures of value-creation and milestones that will demonstrate progress, and steps taken if any obstacles are anticipated or incurred |
• | ensuring the integrity of financial statements |
• | making independent decisions regarding mergers, acquisitions and disposals |
• | establishing appropriate executive compensation structures |
• | addressing business issues, including environmental and social issues, when they have the potential to materially impact company reputation and performance |
• | current or former employment at the company or a subsidiary within the past several years |
• | being, or representing, a shareholder with a substantial shareholding in the company |
• | interlocking directorships |
• | having any other interest, business or other relationship which could, or could reasonably be perceived to, materially interfere with the director’s ability to act in the best interests of the company |
1) | publish a disclosure in line with industry-specific SASB guidelines by year-end, if they have not already done so, or disclose a similar set of data in a way that is relevant to their particular business; and |
2) | disclose climate-related risks in line with the TCFD’s recommendations, if they have not already done so. This should include the company’s plan for operating under a scenario where the Paris Agreement’s goal of limiting global warming to less than two degrees is fully realized, as expressed by the TCFD guidelines. |
• | The company has already taken sufficient steps to address the concern |
• | The company is in the process of actively implementing a response |
• | There is a clear and material economic disadvantage to the company in the near-term if the issue is not addressed in the manner requested by the shareholder proposal |
• | BlackRock clients who may be issuers of securities or proponents of shareholder resolutions |
• | BlackRock business partners or third parties who may be issuers of securities or proponents of shareholder resolutions |
• | BlackRock employees who may sit on the boards of public companies held in Funds managed by BlackRock |
• | Significant BlackRock, Inc. investors who may be issuers of securities held in Funds managed by BlackRock |
• | Securities of BlackRock, Inc. or BlackRock investment funds held in Funds managed by BlackRock |
• | BlackRock, Inc. board members who serve as senior executives of public companies held in Funds managed by BlackRock |
• | Adopted the Guidelines which are designed to protect and enhance the economic value of the companies in which BlackRock invests on behalf of clients. |
• | Established a reporting structure that separates BIS from employees with sales, vendor management or business partnership roles. In addition, BlackRock seeks to ensure that all engagements with corporate issuers, dissident shareholders or shareholder proponents are managed consistently and without regard to BlackRock’s relationship with such parties. Clients or business partners are not given special treatment or differentiated access to BIS. BIS prioritizes engagements based on factors including but not limited to our need for additional information to make a voting decision or our view on the likelihood that an engagement could lead to positive outcome(s) over time for the economic value of the company. Within the normal course of business, BIS may engage directly with BlackRock clients, business partners and/or third parties, and/or with employees with sales, vendor management or business partnership roles, in discussions regarding our approach to stewardship, general corporate governance matters, client reporting needs, and/or to otherwise ensure that proxy-related client service levels are met. |
• | Determined to engage, in certain instances, an independent fiduciary to vote proxies as a further safeguard to avoid potential conflicts of interest, to satisfy regulatory compliance requirements, or as may be otherwise required by applicable law. In such circumstances, the independent fiduciary provides BlackRock’s proxy voting agent with instructions, in accordance with the Guidelines, as to how to vote such proxies, and BlackRock’s proxy voting agent votes the proxy in accordance with the independent fiduciary’s determination. BlackRock uses an independent fiduciary to vote proxies of (i) any company that is affiliated with BlackRock, Inc., (ii) any public company that includes BlackRock employees on its board of directors, (iii) The PNC Financial Services Group, Inc., (iv) any public company of which a BlackRock, Inc. board member serves as a senior executive, and (v) companies when legal or regulatory requirements compel BlackRock to use an independent fiduciary. In selecting an independent fiduciary, we assess several characteristics, including but not limited to: independence, an ability to analyze proxy issues and vote in the best economic interest of our clients, reputation for reliability and integrity, and operational capacity to accurately deliver the assigned votes in a timely manner. We may engage more than one independent fiduciary, in part in order to mitigate potential or perceived conflicts of interest at an independent fiduciary. The Global Committee appoints and reviews the performance of the independent fiduciar(ies), generally on an annual basis. |
Contents | |
Introduction | A-16 |
Voting guidelines | A-16 |
Boards and directors | A-16 |
- Director elections | A-16 |
- Independence | A-16 |
- Oversight | A-17 |
- Responsiveness to shareholders | A-17 |
- Shareholder rights | A-17 |
- Board composition and effectiveness | A-18 |
- Board size | A-19 |
- CEO and management succession planning | A-19 |
- Classified board of directors / staggered terms | A-19 |
- Contested director elections | A-19 |
- Cumulative voting | A-19 |
- Director compensation and equity programs | A-19 |
- Majority vote requirements | A-19 |
- Risk oversight | A-20 |
- Separation of chairman and CEO | A-20 |
Auditors and audit-related issues | A-20 |
Capital structure proposals | A-21 |
- Equal voting rights | A-21 |
- Blank check preferred stock | A-21 |
- Increase in authorized common shares | A-21 |
- Increase or issuance of preferred stock | A-21 |
- Stock splits | A-22 |
Mergers, asset sales, and other special transactions | A-22 |
- Poison pill plans | A-22 |
- Reimbursement of expenses for successful shareholder campaigns | A-22 |
Executive Compensation | A-22 |
- Advisory resolutions on executive compensation (“Say on Pay”) | A-23 |
- Advisory votes on the frequency of Say on Pay resolutions | A-23 |
- Claw back proposals | A-23 |
- Employee stock purchase plans | A-23 |
- Equity compensation plans | A-23 |
- Golden parachutes | A-23 |
- Option exchanges | A-24 |
- Pay-for-Performance plans | A-24 |
- Supplemental executive retirement plans | A-24 |
Environmental and social issues | A-24 |
- Climate risk | A-25 |
- Corporate political activities | A-26 |
General corporate governance matters | A-26 |
- Adjourn meeting to solicit additional votes | A-26 |
- Bundled proposals | A-26 |
- Exclusive forum provisions | A-26 |
- Multi-jurisdictional companies | A-26 |
- Other business | A-27 |
- Reincorporation | A-27 |
- IPO governance | A-27 |
Contents | |
Shareholder Protections | A-27 |
- Amendment to charter / articles / bylaws | A-27 |
- Proxy access | A-28 |
- Right to act by written consent | A-28 |
- Right to call a special meeting | A-28 |
- Simple majority voting | A-28 |
• | Boards and directors |
• | Auditors and audit-related issues |
• | Capital structure |
• | Mergers, asset sales, and other special transactions |
• | Executive compensation |
• | Environmental and social issues |
• | General corporate governance matters |
• | Shareholder protections |
• | Employment as a senior executive by the company or a subsidiary within the past five years |
• | An equity ownership in the company in excess of 20% |
• | Having any other interest, business, or relationship which could, or could reasonably be perceived to, materially interfere with the director’s ability to act in the best interests of the company |
• | Where the board has failed to exercise oversight with regard to accounting practices or audit oversight, we will consider voting against the current audit committee, and any other members of the board who may be responsible. For example, this may apply to members of the audit committee during a period when the board failed to facilitate quality, independent auditing if substantial accounting irregularities suggest insufficient oversight by that committee |
• | Members of the compensation committee during a period in which executive compensation appears excessive relative to performance and peers, and where we believe the compensation committee has not already substantially addressed this issue |
• | The chair of the nominating / governance committee, or where no chair exists, the nominating / governance committee member with the longest tenure, where the board is not comprised of a majority of independent directors. However, this would not apply in the case of a controlled company |
• | Where it appears the director has acted (at the company or at other companies) in a manner that compromises his / her reliability to represent the best long-term economic interests of shareholders |
• | Where a director has a pattern of poor attendance at combined board and applicable key committee meetings. Excluding exigent circumstances, BlackRock generally considers attendance at less than 75% of the combined board and applicable key committee meetings by a board member to be poor attendance |
• | Where a director serves on an excess number of boards, which may limit his / her capacity to focus on each board’s requirements. The following illustrates the maximum number of boards on which a director may serve, before he / she is considered to be over-committed: |
Public Company CEO |
# Outside Public Boards* |
Total # of Public Boards |
|||
Director A | x | 1 | 2 | ||
Director B | 3 | 4 |
* | In addition to the company under review |
• | The independent chair or lead independent director, members of the nominating / governance committee, and / or the longest tenured director(s), where we observe a lack of board responsiveness to shareholders, evidence of board entrenchment, and / or failure to promote adequate board succession planning |
• | The chair of the nominating / governance committee, or where no chair exists, the nominating / governance committee member with the longest tenure, where board member(s) at the most recent election of directors have received withhold votes from more than 30% of shares voted and the board has not taken appropriate action to respond to shareholder concerns. This may not apply in cases where BlackRock did not support the initial withhold vote |
• | The independent chair or lead independent director and / or members of the nominating / governance committee, where a board fails to implement shareholder proposals that receive a majority of votes cast at a prior shareholder meeting, and the proposals, in our view, have a direct and substantial impact on shareholders’ fundamental rights or long-term economic interests |
• | The independent chair or lead independent director and members of the governance committee, where a board implements or renews a poison pill without shareholder approval |
• | The independent chair or lead independent director and members of the governance committee, where a board amends the charter / articles / bylaws such that the effect may be to entrench directors or to significantly reduce shareholder rights |
• | Members of the compensation committee where the company has repriced options without shareholder approval |
• | If a board maintains a classified structure, it is possible that the director(s) with whom we have a particular concern may not be subject to election in the year that the concern arises. In such situations, if we have a concern regarding a committee or committee chair that is not up for re-election, we will generally register our concern by withholding votes from all available members of the relevant committee |
• | The mix of competencies, experience, and other qualities required to effectively oversee and guide management in light of the stated long-term strategy of the company |
• | The process by which candidates are identified and selected, including whether professional firms or other sources outside of incumbent directors’ networks have been engaged to identify and / or assess candidates |
• | The process by which boards evaluate themselves and any significant outcomes of the evaluation process, without divulging inappropriate and / or sensitive details |
• | The consideration given to board diversity, including, but not limited to, gender, ethnicity, race, age, experience, geographic location, skills, and perspective in the nomination process |
Combined Chair / CEO Model |
Separate Chair Model |
||||
Chair / CEO | Lead Director | Chair | |||
Board Meetings | Authority to call full meetings of the board of directors | Attends full meetings of the board of directors Authority to call meetings of independent directors Briefs CEO on issues arising from executive sessions |
Authority to call full meetings of the board of directors | ||
Agenda | Primary responsibility for shaping board agendas, consulting with the lead director | Collaborates with chair / CEO to set board agenda and board information | Primary responsibility for shaping board agendas, in conjunction with CEO | ||
Board Communications | Communicates with all directors on key issues and concerns outside of full board meetings | Facilitates discussion among independent directors on key issues and concerns outside of full board meetings, including contributing to the oversight of CEO and management succession planning | Facilitates discussion among independent directors on key issues and concerns outside of full board meetings, including contributing to the oversight of CEO and management succession planning |
• | Appears to have a legitimate financing motive for requesting blank check authority |
• | Has committed publicly that blank check preferred shares will not be used for anti-takeover purposes |
• | Has a history of using blank check preferred stock for financings |
• | Has blank check preferred stock previously outstanding such that an increase would not necessarily provide further anti-takeover protection but may provide greater financing flexibility |
• | The degree to which the proposed transaction represents a premium to the company’s trading price. We consider the share price over multiple time periods prior to the date of the merger announcement. In most cases, business combinations should provide a premium. We may consider comparable transaction analyses provided by the parties’ financial advisors and our own valuation assessments. For companies facing insolvency or bankruptcy, a premium may not apply |
• | There should be clear strategic, operational, and / or financial rationale for the combination |
• | Unanimous board approval and arm’s-length negotiations are preferred. We will consider whether the transaction involves a dissenting board or does not appear to be the result of an arm’s-length bidding process. We may also consider whether executive and / or board members’ financial interests in a given transaction appear likely to affect their ability to place shareholders’ interests before their own |
• | We prefer transaction proposals that include the fairness opinion of a reputable financial advisor assessing the value of the transaction to shareholders in comparison to recent similar transactions |
• | Whether we believe that the triggering event is in the best interest of shareholders |
• | Whether management attempted to maximize shareholder value in the triggering event |
• | The percentage of total premium or transaction value that will be transferred to the management team, rather than shareholders, as a result of the golden parachute payment |
• | Whether excessively large excise tax gross-up payments are part of the pay-out |
• | Whether the pay package that serves as the basis for calculating the golden parachute payment was reasonable in light of performance and peers |
• | Whether the golden parachute payment will have the effect of rewarding a management team that has failed to effectively manage the company |
• | The company has experienced significant stock price decline as a result of macroeconomic trends, not individual company performance |
• | Directors and executive officers are excluded; the exchange is value neutral or value creative to shareholders; tax, accounting, and other technical considerations have been fully contemplated |
• | There is clear evidence that absent repricing, the company will suffer serious employee incentive or retention and recruiting problems |
• | Publish disclosures in line with industry specific SASB guidelines by year-end, if they have not already done so, or disclose a similar set of data in a way that is relevant to their particular business; and |
• | Disclose climate-related risks in line with the TCFD’s recommendations, if they have not already done so. This should include the company’s plan for operating under a scenario where the Paris Agreement’s goal of limiting global warming to less than two degrees is fully realized, as expressed by the TCFD guidelines. |
• | See our commentary on our approach to engagement on TCFD and SASB aligned reporting for greater detail of our expectations. |
• | The company has already taken sufficient steps to address the concern |
• | The company is in the process of actively implementing a response |
• | There is a clear and material economic disadvantage to the company in the near-term if the issue is not addressed in the manner requested by the shareholder proposal |
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
@,<%&4.K:T0)BA9;DG9 )\B<.8GEQ( MIA,4.()>+&_668<%#QQ@IAMNVNFG%K?$1D4!-=)A@1F[1(!D-T3U>0*C4>6@ M* J3LK"=! <\P "1*!S:!0;BW 8>! U),(LK%9J#RU:SX0;4=K,4F8DQLEX0 M:Y472(,(<*!RPJNMN%C0S0AJ3 !<+&6JLQJ79Q44.C9D3J QG^Q7G%- ]( M4,"T$#"0JS8C6$O!-&@AP4 $4R 1BP3GIEM;! ,T0 &F!E&C+4'&99LNINQ" M(&$^A,!5 /J&J5NGI@VZVP MQ"$B+8[<<3 M4:) W'#$<01[L3CQA!39@\H MX =6((N< 58/($"!QS)0LZ!WXN!;U,EY^3$409D^,.\8ZL HBTD(AL+;/''38[19R[^) UGB-/ MJ<8% 8#7#7V9:DP!&8U2(8!!50BFC:?6T?W;% ]8D&G0(\\VN,SYJ&P:%7;C MFT_C(PO^(0EYFD+-5H#/!KC,?*O1H0[^@4W)^DSQ"PI/AP6OKJK+?N^NNP MQR[[[,8-[@L&6.)0BJ4:CU#*[K0#4>R$OWC1D++6X6Y1+\C.-H'RL[&4%C# MX69:\?D40($5,E19/+#!3D)K+[-6J7;IV9+ +KHBD+I^9@50LQP [\@_# 'V MTY]]2P>$I!.. *HI^R9X@ ["< T J"G4!E@)\GA" ,#4 $R\.-#$3J MD%:'KZ& S =7^*#>T 2!6'2+A ADB@!**+"@M0J#*_O&%!J5'%.88F[LHV$# ML"*! ;"O*]^P@ L9IXU#F&)U8HL:@58F@ZQ=X"$?2@L4[_9$(=VMA=^ +*H M 0 7"JD1X %HU0PS(( K@O$!#LA, 'PX@@9D$0'?"!H57'-$#F8J?I(#5S (@A"R"D
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